input stringlengths 26 367 | metadata stringlengths 184 193 | answers stringlengths 37 373 | evidence stringlengths 17 1.79k | context stringlengths 700 16.8k | program stringlengths 9 122 |
|---|---|---|---|---|---|
what is the the interest expense in 2009? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_49.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "380", "exe_answer": 3.8} | {"text_1": "if libor changes by 100 basis points , our annual interest expense would change by $ 3.8 million ."} | {"pre_text": ["interest rate to a variable interest rate based on the three-month libor plus 2.05% ( 2.05 % ) ( 2.34% ( 2.34 % ) as of october 31 , 2009 ) .", "if libor changes by 100 basis points , our annual interest expense would change by $ 3.8 million .", "foreign currency exposure as more fully described in note 2i .", "in the notes to consolidated financial statements contained in item 8 of this annual report on form 10-k , we regularly hedge our non-u.s .", "dollar-based exposures by entering into forward foreign currency exchange contracts .", "the terms of these contracts are for periods matching the duration of the underlying exposure and generally range from one month to twelve months .", "currently , our largest foreign currency exposure is the euro , primarily because our european operations have the highest proportion of our local currency denominated expenses .", "relative to foreign currency exposures existing at october 31 , 2009 and november 1 , 2008 , a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates over the course of the year would not expose us to significant losses in earnings or cash flows because we hedge a high proportion of our year-end exposures against fluctuations in foreign currency exchange rates .", "the market risk associated with our derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions , assets and liabilities being hedged .", "the counterparties to the agreements relating to our foreign exchange instruments consist of a number of major international financial institutions with high credit ratings .", "we do not believe that there is significant risk of nonperformance by these counterparties because we continually monitor the credit ratings of such counterparties .", "while the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions , they do not represent the amount of our exposure to credit risk .", "the amounts potentially subject to credit risk ( arising from the possible inability of counterparties to meet the terms of their contracts ) are generally limited to the amounts , if any , by which the counterparties 2019 obligations under the contracts exceed our obligations to the counterparties .", "the following table illustrates the effect that a 10% ( 10 % ) unfavorable or favorable movement in foreign currency exchange rates , relative to the u.s .", "dollar , would have on the fair value of our forward exchange contracts as of october 31 , 2009 and november 1 , 2008: ."], "post_text": ["fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset ( liability ) .", ".", ".", ".", ".", ".", ".", ".", ".", "$ 20132 $ ( 9457 ) fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability .", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", "$ ( 6781 ) $ ( 38294 ) the calculation assumes that each exchange rate would change in the same direction relative to the u.s .", "dollar .", "in addition to the direct effects of changes in exchange rates , such changes typically affect the volume of sales or the foreign currency sales price as competitors 2019 products become more or less attractive .", "our sensitivity analysis of the effects of changes in foreign currency exchange rates does not factor in a potential change in sales levels or local currency selling prices. ."], "table": [["", "october 31 2009", "november 1 2008"], ["fair value of forward exchange contracts asset ( liability )", "$ 6427", "$ -23158 ( 23158 )"], ["fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset ( liability )", "$ 20132", "$ -9457 ( 9457 )"], ["fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability", "$ -6781 ( 6781 )", "$ -38294 ( 38294 )"]], "table_ori": [["", "October 31, 2009", "November 1, 2008"], ["Fair value of forward exchange contracts asset (liability)", "$6,427", "$(23,158)"], ["Fair value of forward exchange contracts after a 10% unfavorable movement in foreign currency exchange rates asset (liability)", "$20,132", "$(9,457)"], ["Fair value of forward exchange contracts after a 10% favorable movement in foreign currency exchange rates liability", "$(6,781)", "$(38,294)"]]} | divide(100, 100), divide(3.8, #0) |
what is the expected growth rate in amortization expense in 2010? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_59.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "-27.0%", "exe_answer": -0.26689} | {"table_1": "fiscal years the 2010 of amortization expense is $ 5425 ;", "text_2": "amortization expense from continuing operations , related to intangibles was $ 7.4 million , $ 9.3 million and $ 9.2 million in fiscal 2009 , 2008 and 2007 , respectively ."} | {"pre_text": ["intangible assets are amortized on a straight-line basis over their estimated useful lives or on an accelerated method of amortization that is expected to reflect the estimated pattern of economic use .", "the remaining amortization expense will be recognized over a weighted-average period of approximately 0.9 years .", "amortization expense from continuing operations , related to intangibles was $ 7.4 million , $ 9.3 million and $ 9.2 million in fiscal 2009 , 2008 and 2007 , respectively .", "the company expects annual amortization expense for these intangible assets to be: ."], "post_text": ["g .", "grant accounting certain of the company 2019s foreign subsidiaries have received various grants from governmental agencies .", "these grants include capital , employment and research and development grants .", "capital grants for the acquisition of property and equipment are netted against the related capital expenditures and amortized as a credit to depreciation expense over the useful life of the related asset .", "employment grants , which relate to employee hiring and training , and research and development grants are recognized in earnings in the period in which the related expenditures are incurred by the company .", "h .", "translation of foreign currencies the functional currency for the company 2019s foreign sales and research and development operations is the applicable local currency .", "gains and losses resulting from translation of these foreign currencies into u.s .", "dollars are recorded in accumulated other comprehensive ( loss ) income .", "transaction gains and losses and remeasurement of foreign currency denominated assets and liabilities are included in income currently , including those at the company 2019s principal foreign manufacturing operations where the functional currency is the u.s .", "dollar .", "foreign currency transaction gains or losses included in other expenses , net , were not material in fiscal 2009 , 2008 or 2007 .", "i .", "derivative instruments and hedging agreements foreign exchange exposure management 2014 the company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates .", "such exposures result from the portion of the company 2019s operations , assets and liabilities that are denominated in currencies other than the u.s .", "dollar , primarily the euro ; other exposures include the philippine peso and the british pound .", "these foreign currency exchange contracts are entered into to support transactions made in the normal course of business , and accordingly , are not speculative in nature .", "the contracts are for periods consistent with the terms of the underlying transactions , generally one year or less .", "hedges related to anticipated transactions are designated and documented at the inception of the respective hedges as cash flow hedges and are evaluated for effectiveness monthly .", "derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified .", "as the terms of the contract and the underlying transaction are matched at inception , forward contract effectiveness is calculated by comparing the change in fair value of the contract to the change in the forward value of the anticipated transaction , with the effective portion of the gain or loss on the derivative instrument reported as a component of accumulated other comprehensive ( loss ) income ( oci ) in shareholders 2019 equity and reclassified into earnings in the same period during which the hedged transaction affects earnings .", "any residual change in fair value of the instruments , or ineffectiveness , is recognized immediately in other income/expense .", "additionally , the company enters into forward foreign currency contracts that economically hedge the gains and losses generated by the remeasurement of certain recorded assets and liabilities in a non-functional currency .", "changes in the fair value of these undesignated hedges are recognized in other income/expense immediately as an offset to the changes in the fair value of the asset or liability being hedged .", "analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["fiscal years", "amortization expense"], ["2010", "$ 5425"], ["2011", "$ 1430"]], "table_ori": [["Fiscal Years", "Amortization Expense"], ["2010", "$5,425"], ["2011", "$1,430"]]} | divide(5425, const_1000), subtract(#0, 7.4), divide(#1, 7.4) |
what is the net difference between in amounts used to as hedging instruments? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_60.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "247", "exe_answer": 247.0} | {"text_22": "the total notional amount of derivative instruments designated as hedging instruments as of october 31 , 2009 is as follows : $ 375 million of interest rate swap agreements accounted as fair value hedges , and $ 128.0 million of analog devices , inc ."} | {"pre_text": ["as of october 31 , 2009 , the total notional amount of these undesignated hedges was $ 38 million .", "the fair value of these hedging instruments in the company 2019s condensed consolidated balance sheet as of october 31 , 2009 was immaterial .", "interest rate exposure management 2014 on june 30 , 2009 , the company entered into interest rate swap transactions related to its outstanding notes where the company swapped the notional amount of its $ 375 million of fixed rate debt at 5.0% ( 5.0 % ) into floating interest rate debt through july 1 , 2014 .", "under the terms of the swaps , the company will ( i ) receive on the $ 375 million notional amount a 5.0% ( 5.0 % ) annual interest payment that is paid in two installments on the 1st of every january and july , commencing january 1 , 2010 through and ending on the maturity date ; and ( ii ) pay on the $ 375 million notional amount an annual three-month libor plus 2.05% ( 2.05 % ) ( 2.34% ( 2.34 % ) as of october 31 , 2009 ) interest payment , payable in four installments on the 1st of every january , april , july and october , commencing on october 1 , 2009 and ending on the maturity date .", "the libor based rate is set quarterly three months prior to the date of the interest payment .", "the company designated these swaps as fair value hedges .", "the fair value of the swaps at inception were zero and subsequent changes in the fair value of the interest rate swaps were reflected in the carrying value of the interest rate swaps on the balance sheet .", "the carrying value of the debt on the balance sheet was adjusted by an equal and offsetting amount .", "the gain or loss on the hedged item ( that is fixed- rate borrowings ) attributable to the hedged benchmark interest rate risk and the offsetting gain or loss on the related interest rate swaps as of october 31 , 2009 is as follows : income statement classification gain/ ( loss ) on gain/ ( loss ) on note net income effect ."], "post_text": ["the amounts earned and owed under the swap agreements are accrued each period and are reported in interest expense .", "there was no ineffectiveness recognized in any of the periods presented .", "the market risk associated with the company 2019s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions , assets and liabilities being hedged .", "the counterparties to the agreements relating to the company 2019s derivative instruments consist of a number of major international financial institutions with high credit ratings .", "the company does not believe that there is significant risk of nonperformance by these counterparties because the company continually monitors the credit ratings of such counterparties .", "furthermore , none of the company 2019s derivative transactions are subject to collateral or other security arrangements and none contain provisions that are dependent on the company 2019s credit ratings from any credit rating agency .", "while the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions , they do not represent the amount of the company 2019s exposure to credit risk .", "the amounts potentially subject to credit risk ( arising from the possible inability of counterparties to meet the terms of their contracts ) are generally limited to the amounts , if any , by which the counterparties 2019 obligations under the contracts exceed the obligations of the company to the counterparties .", "as a result of the above considerations , the company does not consider the risk of counterparty default to be significant .", "the company records the fair value of its derivative financial instruments in the consolidated financial statements in other current assets , other assets or accrued liabilities , depending on their net position , regardless of the purpose or intent for holding the derivative contract .", "changes in the fair value of the derivative financial instruments are either recognized periodically in earnings or in shareholders 2019 equity as a component of oci .", "changes in the fair value of cash flow hedges are recorded in oci and reclassified into earnings when the underlying contract matures .", "changes in the fair values of derivatives not qualifying for hedge accounting are reported in earnings as they occur .", "the total notional amount of derivative instruments designated as hedging instruments as of october 31 , 2009 is as follows : $ 375 million of interest rate swap agreements accounted as fair value hedges , and $ 128.0 million of analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["income statement classification", "gain/ ( loss ) on swaps", "gain/ ( loss ) on note", "net income effect"], ["other income", "$ 6109", "$ -6109 ( 6109 )", "$ 2014"]], "table_ori": [["Income Statement Classification", "Gain/(Loss) on Swaps", "Gain/(Loss) on Note", "Net Income Effect"], ["Other income", "$6,109", "$(6,109)", "$—"]]} | subtract(375, 128.0) |
what is the growth rate in amortization expense in 2009? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_59.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "-20.4%", "exe_answer": -0.2043} | {"text_2": "amortization expense from continuing operations , related to intangibles was $ 7.4 million , $ 9.3 million and $ 9.2 million in fiscal 2009 , 2008 and 2007 , respectively ."} | {"pre_text": ["intangible assets are amortized on a straight-line basis over their estimated useful lives or on an accelerated method of amortization that is expected to reflect the estimated pattern of economic use .", "the remaining amortization expense will be recognized over a weighted-average period of approximately 0.9 years .", "amortization expense from continuing operations , related to intangibles was $ 7.4 million , $ 9.3 million and $ 9.2 million in fiscal 2009 , 2008 and 2007 , respectively .", "the company expects annual amortization expense for these intangible assets to be: ."], "post_text": ["g .", "grant accounting certain of the company 2019s foreign subsidiaries have received various grants from governmental agencies .", "these grants include capital , employment and research and development grants .", "capital grants for the acquisition of property and equipment are netted against the related capital expenditures and amortized as a credit to depreciation expense over the useful life of the related asset .", "employment grants , which relate to employee hiring and training , and research and development grants are recognized in earnings in the period in which the related expenditures are incurred by the company .", "h .", "translation of foreign currencies the functional currency for the company 2019s foreign sales and research and development operations is the applicable local currency .", "gains and losses resulting from translation of these foreign currencies into u.s .", "dollars are recorded in accumulated other comprehensive ( loss ) income .", "transaction gains and losses and remeasurement of foreign currency denominated assets and liabilities are included in income currently , including those at the company 2019s principal foreign manufacturing operations where the functional currency is the u.s .", "dollar .", "foreign currency transaction gains or losses included in other expenses , net , were not material in fiscal 2009 , 2008 or 2007 .", "i .", "derivative instruments and hedging agreements foreign exchange exposure management 2014 the company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates .", "such exposures result from the portion of the company 2019s operations , assets and liabilities that are denominated in currencies other than the u.s .", "dollar , primarily the euro ; other exposures include the philippine peso and the british pound .", "these foreign currency exchange contracts are entered into to support transactions made in the normal course of business , and accordingly , are not speculative in nature .", "the contracts are for periods consistent with the terms of the underlying transactions , generally one year or less .", "hedges related to anticipated transactions are designated and documented at the inception of the respective hedges as cash flow hedges and are evaluated for effectiveness monthly .", "derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified .", "as the terms of the contract and the underlying transaction are matched at inception , forward contract effectiveness is calculated by comparing the change in fair value of the contract to the change in the forward value of the anticipated transaction , with the effective portion of the gain or loss on the derivative instrument reported as a component of accumulated other comprehensive ( loss ) income ( oci ) in shareholders 2019 equity and reclassified into earnings in the same period during which the hedged transaction affects earnings .", "any residual change in fair value of the instruments , or ineffectiveness , is recognized immediately in other income/expense .", "additionally , the company enters into forward foreign currency contracts that economically hedge the gains and losses generated by the remeasurement of certain recorded assets and liabilities in a non-functional currency .", "changes in the fair value of these undesignated hedges are recognized in other income/expense immediately as an offset to the changes in the fair value of the asset or liability being hedged .", "analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["fiscal years", "amortization expense"], ["2010", "$ 5425"], ["2011", "$ 1430"]], "table_ori": [["Fiscal Years", "Amortization Expense"], ["2010", "$5,425"], ["2011", "$1,430"]]} | subtract(7.4, 9.3), divide(#0, 9.3) |
what is the net change in the balance of total amounts of uncertain tax positions from 2007 to 2009? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_90.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "8272", "exe_answer": 8272.0} | {"table_4": "balance november 3 2007 the balance october 31 2009 of $ 9889 is $ 18161 ;"} | {"pre_text": ["included in other non-current liabilities , because the company believes that the ultimate payment or settlement of these liabilities will not occur within the next twelve months .", "prior to the adoption of these provisions , these amounts were included in current income tax payable .", "the company includes interest and penalties related to unrecognized tax benefits within the provision for taxes in the condensed consolidated statements of income , and as a result , no change in classification was made upon adopting these provisions .", "the condensed consolidated statements of income for fiscal year 2009 and fiscal year 2008 include $ 1.7 million and $ 1.3 million , respectively , of interest and penalties related to these uncertain tax positions .", "due to the complexity associated with its tax uncertainties , the company cannot make a reasonably reliable estimate as to the period in which it expects to settle the liabilities associated with these uncertain tax positions .", "the following table summarizes the changes in the total amounts of uncertain tax positions for fiscal 2008 and fiscal 2009. ."], "post_text": ["fiscal year 2004 and 2005 irs examination during the fourth quarter of fiscal 2007 , the irs completed its field examination of the company 2019s fiscal years 2004 and 2005 .", "on january 2 , 2008 , the irs issued its report for fiscal 2004 and 2005 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 46 million .", "the company has concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "the company 2019s initial meetings with the appellate division of the irs were held during fiscal year 2009 .", "two of the unresolved matters are one-time issues and pertain to section 965 of the internal revenue code related to the beneficial tax treatment of dividends from foreign owned companies under the american jobs creation act .", "the other matters pertain to the computation of research and development ( r&d ) tax credits and the profits earned from manufacturing activities carried on outside the united states .", "these latter two matters could impact taxes payable for fiscal 2004 and 2005 as well as for subsequent years .", "fiscal year 2006 and 2007 irs examination during the third quarter of fiscal 2009 , the irs completed its field examination of the company 2019s fiscal years 2006 and 2007 .", "the irs and the company have agreed on the treatment of a number of issues that have been included in an issue resolutions agreement related to the 2006 and 2007 tax returns .", "however , no agreement was reached on the tax treatment of a number of issues , including the same r&d credit and foreign manufacturing issues mentioned above related to fiscal 2004 and 2005 , the pricing of intercompany sales ( transfer pricing ) , and the deductibility of certain stock option compensation expenses .", "during the third quarter of fiscal 2009 , the irs issued its report for fiscal 2006 and fiscal 2007 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 195 million .", "the company concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "with the exception of the analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["balance november 3 2007", "$ 9889"], ["additions for tax positions of current year", "3861"], ["balance november 1 2008", "13750"], ["additions for tax positions of current year", "4411"], ["balance october 31 2009", "$ 18161"]], "table_ori": [["Balance, November 3, 2007", "$9,889"], ["Additions for tax positions of current year", "3,861"], ["Balance, November 1, 2008", "13,750"], ["Additions for tax positions of current year", "4,411"], ["Balance, October 31, 2009", "$18,161"]]} | subtract(18161, 9889) |
what is the percentage increase in interest expanse and penalties in 2009? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_90.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "30.8%", "exe_answer": 0.30769} | {"text_3": "the condensed consolidated statements of income for fiscal year 2009 and fiscal year 2008 include $ 1.7 million and $ 1.3 million , respectively , of interest and penalties related to these uncertain tax positions ."} | {"pre_text": ["included in other non-current liabilities , because the company believes that the ultimate payment or settlement of these liabilities will not occur within the next twelve months .", "prior to the adoption of these provisions , these amounts were included in current income tax payable .", "the company includes interest and penalties related to unrecognized tax benefits within the provision for taxes in the condensed consolidated statements of income , and as a result , no change in classification was made upon adopting these provisions .", "the condensed consolidated statements of income for fiscal year 2009 and fiscal year 2008 include $ 1.7 million and $ 1.3 million , respectively , of interest and penalties related to these uncertain tax positions .", "due to the complexity associated with its tax uncertainties , the company cannot make a reasonably reliable estimate as to the period in which it expects to settle the liabilities associated with these uncertain tax positions .", "the following table summarizes the changes in the total amounts of uncertain tax positions for fiscal 2008 and fiscal 2009. ."], "post_text": ["fiscal year 2004 and 2005 irs examination during the fourth quarter of fiscal 2007 , the irs completed its field examination of the company 2019s fiscal years 2004 and 2005 .", "on january 2 , 2008 , the irs issued its report for fiscal 2004 and 2005 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 46 million .", "the company has concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "the company 2019s initial meetings with the appellate division of the irs were held during fiscal year 2009 .", "two of the unresolved matters are one-time issues and pertain to section 965 of the internal revenue code related to the beneficial tax treatment of dividends from foreign owned companies under the american jobs creation act .", "the other matters pertain to the computation of research and development ( r&d ) tax credits and the profits earned from manufacturing activities carried on outside the united states .", "these latter two matters could impact taxes payable for fiscal 2004 and 2005 as well as for subsequent years .", "fiscal year 2006 and 2007 irs examination during the third quarter of fiscal 2009 , the irs completed its field examination of the company 2019s fiscal years 2006 and 2007 .", "the irs and the company have agreed on the treatment of a number of issues that have been included in an issue resolutions agreement related to the 2006 and 2007 tax returns .", "however , no agreement was reached on the tax treatment of a number of issues , including the same r&d credit and foreign manufacturing issues mentioned above related to fiscal 2004 and 2005 , the pricing of intercompany sales ( transfer pricing ) , and the deductibility of certain stock option compensation expenses .", "during the third quarter of fiscal 2009 , the irs issued its report for fiscal 2006 and fiscal 2007 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 195 million .", "the company concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "with the exception of the analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["balance november 3 2007", "$ 9889"], ["additions for tax positions of current year", "3861"], ["balance november 1 2008", "13750"], ["additions for tax positions of current year", "4411"], ["balance october 31 2009", "$ 18161"]], "table_ori": [["Balance, November 3, 2007", "$9,889"], ["Additions for tax positions of current year", "3,861"], ["Balance, November 1, 2008", "13,750"], ["Additions for tax positions of current year", "4,411"], ["Balance, October 31, 2009", "$18,161"]]} | subtract(1.7, 1.3), divide(#0, 1.3) |
what is the lobor rate as of october 31 , 2009? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_49.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "29.0%", "exe_answer": 0.0029} | {"text_0": "interest rate to a variable interest rate based on the three-month libor plus 2.05% ( 2.05 % ) ( 2.34% ( 2.34 % ) as of october 31 , 2009 ) ."} | {"pre_text": ["interest rate to a variable interest rate based on the three-month libor plus 2.05% ( 2.05 % ) ( 2.34% ( 2.34 % ) as of october 31 , 2009 ) .", "if libor changes by 100 basis points , our annual interest expense would change by $ 3.8 million .", "foreign currency exposure as more fully described in note 2i .", "in the notes to consolidated financial statements contained in item 8 of this annual report on form 10-k , we regularly hedge our non-u.s .", "dollar-based exposures by entering into forward foreign currency exchange contracts .", "the terms of these contracts are for periods matching the duration of the underlying exposure and generally range from one month to twelve months .", "currently , our largest foreign currency exposure is the euro , primarily because our european operations have the highest proportion of our local currency denominated expenses .", "relative to foreign currency exposures existing at october 31 , 2009 and november 1 , 2008 , a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates over the course of the year would not expose us to significant losses in earnings or cash flows because we hedge a high proportion of our year-end exposures against fluctuations in foreign currency exchange rates .", "the market risk associated with our derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions , assets and liabilities being hedged .", "the counterparties to the agreements relating to our foreign exchange instruments consist of a number of major international financial institutions with high credit ratings .", "we do not believe that there is significant risk of nonperformance by these counterparties because we continually monitor the credit ratings of such counterparties .", "while the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions , they do not represent the amount of our exposure to credit risk .", "the amounts potentially subject to credit risk ( arising from the possible inability of counterparties to meet the terms of their contracts ) are generally limited to the amounts , if any , by which the counterparties 2019 obligations under the contracts exceed our obligations to the counterparties .", "the following table illustrates the effect that a 10% ( 10 % ) unfavorable or favorable movement in foreign currency exchange rates , relative to the u.s .", "dollar , would have on the fair value of our forward exchange contracts as of october 31 , 2009 and november 1 , 2008: ."], "post_text": ["fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset ( liability ) .", ".", ".", ".", ".", ".", ".", ".", ".", "$ 20132 $ ( 9457 ) fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability .", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", ".", "$ ( 6781 ) $ ( 38294 ) the calculation assumes that each exchange rate would change in the same direction relative to the u.s .", "dollar .", "in addition to the direct effects of changes in exchange rates , such changes typically affect the volume of sales or the foreign currency sales price as competitors 2019 products become more or less attractive .", "our sensitivity analysis of the effects of changes in foreign currency exchange rates does not factor in a potential change in sales levels or local currency selling prices. ."], "table": [["", "october 31 2009", "november 1 2008"], ["fair value of forward exchange contracts asset ( liability )", "$ 6427", "$ -23158 ( 23158 )"], ["fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset ( liability )", "$ 20132", "$ -9457 ( 9457 )"], ["fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability", "$ -6781 ( 6781 )", "$ -38294 ( 38294 )"]], "table_ori": [["", "October 31, 2009", "November 1, 2008"], ["Fair value of forward exchange contracts asset (liability)", "$6,427", "$(23,158)"], ["Fair value of forward exchange contracts after a 10% unfavorable movement in foreign currency exchange rates asset (liability)", "$20,132", "$(9,457)"], ["Fair value of forward exchange contracts after a 10% favorable movement in foreign currency exchange rates liability", "$(6,781)", "$(38,294)"]]} | subtract(2.34%, 2.05%) |
what percentage did the balance increase from 2007 to 2009? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_90.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "83.6%", "exe_answer": 0.83648} | {"table_4": "balance november 3 2007 the balance october 31 2009 of $ 9889 is $ 18161 ;", "text_5": "the following table summarizes the changes in the total amounts of uncertain tax positions for fiscal 2008 and fiscal 2009. ."} | {"pre_text": ["included in other non-current liabilities , because the company believes that the ultimate payment or settlement of these liabilities will not occur within the next twelve months .", "prior to the adoption of these provisions , these amounts were included in current income tax payable .", "the company includes interest and penalties related to unrecognized tax benefits within the provision for taxes in the condensed consolidated statements of income , and as a result , no change in classification was made upon adopting these provisions .", "the condensed consolidated statements of income for fiscal year 2009 and fiscal year 2008 include $ 1.7 million and $ 1.3 million , respectively , of interest and penalties related to these uncertain tax positions .", "due to the complexity associated with its tax uncertainties , the company cannot make a reasonably reliable estimate as to the period in which it expects to settle the liabilities associated with these uncertain tax positions .", "the following table summarizes the changes in the total amounts of uncertain tax positions for fiscal 2008 and fiscal 2009. ."], "post_text": ["fiscal year 2004 and 2005 irs examination during the fourth quarter of fiscal 2007 , the irs completed its field examination of the company 2019s fiscal years 2004 and 2005 .", "on january 2 , 2008 , the irs issued its report for fiscal 2004 and 2005 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 46 million .", "the company has concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "the company 2019s initial meetings with the appellate division of the irs were held during fiscal year 2009 .", "two of the unresolved matters are one-time issues and pertain to section 965 of the internal revenue code related to the beneficial tax treatment of dividends from foreign owned companies under the american jobs creation act .", "the other matters pertain to the computation of research and development ( r&d ) tax credits and the profits earned from manufacturing activities carried on outside the united states .", "these latter two matters could impact taxes payable for fiscal 2004 and 2005 as well as for subsequent years .", "fiscal year 2006 and 2007 irs examination during the third quarter of fiscal 2009 , the irs completed its field examination of the company 2019s fiscal years 2006 and 2007 .", "the irs and the company have agreed on the treatment of a number of issues that have been included in an issue resolutions agreement related to the 2006 and 2007 tax returns .", "however , no agreement was reached on the tax treatment of a number of issues , including the same r&d credit and foreign manufacturing issues mentioned above related to fiscal 2004 and 2005 , the pricing of intercompany sales ( transfer pricing ) , and the deductibility of certain stock option compensation expenses .", "during the third quarter of fiscal 2009 , the irs issued its report for fiscal 2006 and fiscal 2007 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 195 million .", "the company concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "with the exception of the analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["balance november 3 2007", "$ 9889"], ["additions for tax positions of current year", "3861"], ["balance november 1 2008", "13750"], ["additions for tax positions of current year", "4411"], ["balance october 31 2009", "$ 18161"]], "table_ori": [["Balance, November 3, 2007", "$9,889"], ["Additions for tax positions of current year", "3,861"], ["Balance, November 1, 2008", "13,750"], ["Additions for tax positions of current year", "4,411"], ["Balance, October 31, 2009", "$18,161"]]} | subtract(18161, 9889), divide(#0, 9889) |
what would be the balance if the company suffered the potential total tax liability of the 2006 and 2007 irs examination? | {"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_90.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "$ 17966 million", "exe_answer": 17966.0} | {"table_4": "balance november 3 2007 the balance october 31 2009 of $ 9889 is $ 18161 ;", "text_16": "fiscal year 2006 and 2007 irs examination during the third quarter of fiscal 2009 , the irs completed its field examination of the company 2019s fiscal years 2006 and 2007 .", "text_17": "the irs and the company have agreed on the treatment of a number of issues that have been included in an issue resolutions agreement related to the 2006 and 2007 tax returns .", "text_21": "there are four items with an additional potential total tax liability of $ 195 million ."} | {"pre_text": ["included in other non-current liabilities , because the company believes that the ultimate payment or settlement of these liabilities will not occur within the next twelve months .", "prior to the adoption of these provisions , these amounts were included in current income tax payable .", "the company includes interest and penalties related to unrecognized tax benefits within the provision for taxes in the condensed consolidated statements of income , and as a result , no change in classification was made upon adopting these provisions .", "the condensed consolidated statements of income for fiscal year 2009 and fiscal year 2008 include $ 1.7 million and $ 1.3 million , respectively , of interest and penalties related to these uncertain tax positions .", "due to the complexity associated with its tax uncertainties , the company cannot make a reasonably reliable estimate as to the period in which it expects to settle the liabilities associated with these uncertain tax positions .", "the following table summarizes the changes in the total amounts of uncertain tax positions for fiscal 2008 and fiscal 2009. ."], "post_text": ["fiscal year 2004 and 2005 irs examination during the fourth quarter of fiscal 2007 , the irs completed its field examination of the company 2019s fiscal years 2004 and 2005 .", "on january 2 , 2008 , the irs issued its report for fiscal 2004 and 2005 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 46 million .", "the company has concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "the company 2019s initial meetings with the appellate division of the irs were held during fiscal year 2009 .", "two of the unresolved matters are one-time issues and pertain to section 965 of the internal revenue code related to the beneficial tax treatment of dividends from foreign owned companies under the american jobs creation act .", "the other matters pertain to the computation of research and development ( r&d ) tax credits and the profits earned from manufacturing activities carried on outside the united states .", "these latter two matters could impact taxes payable for fiscal 2004 and 2005 as well as for subsequent years .", "fiscal year 2006 and 2007 irs examination during the third quarter of fiscal 2009 , the irs completed its field examination of the company 2019s fiscal years 2006 and 2007 .", "the irs and the company have agreed on the treatment of a number of issues that have been included in an issue resolutions agreement related to the 2006 and 2007 tax returns .", "however , no agreement was reached on the tax treatment of a number of issues , including the same r&d credit and foreign manufacturing issues mentioned above related to fiscal 2004 and 2005 , the pricing of intercompany sales ( transfer pricing ) , and the deductibility of certain stock option compensation expenses .", "during the third quarter of fiscal 2009 , the irs issued its report for fiscal 2006 and fiscal 2007 , which included proposed adjustments related to these two fiscal years .", "the company has recorded taxes and penalties related to certain of these proposed adjustments .", "there are four items with an additional potential total tax liability of $ 195 million .", "the company concluded , based on discussions with its tax advisors , that these four items are not likely to result in any additional tax liability .", "therefore , the company has not recorded any additional tax liability for these items and is appealing these proposed adjustments through the normal processes for the resolution of differences between the irs and taxpayers .", "with the exception of the analog devices , inc .", "notes to consolidated financial statements 2014 ( continued ) ."], "table": [["balance november 3 2007", "$ 9889"], ["additions for tax positions of current year", "3861"], ["balance november 1 2008", "13750"], ["additions for tax positions of current year", "4411"], ["balance october 31 2009", "$ 18161"]], "table_ori": [["Balance, November 3, 2007", "$9,889"], ["Additions for tax positions of current year", "3,861"], ["Balance, November 1, 2008", "13,750"], ["Additions for tax positions of current year", "4,411"], ["Balance, October 31, 2009", "$18,161"]]} | subtract(18161, 195) |
during the 2012 year , did the equity awards in which the prescribed performance milestones were achieved exceed the equity award compensation expense for equity granted during the year? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_75.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "", "exe_answer": "yes"} | {"table_2": "the granted of number of shares ( in thousands ) is 607 ; the granted of weighted average grant date fair value ( per share ) is 18.13 ;", "text_15": "during the year ended march 31 , 2012 , the company has recorded $ 3.3 million in stock-based compensation expense for equity awards in which the prescribed performance milestones have been achieved or are probable of being achieved ."} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 8 .", "stock award plans and stock-based compensation ( continued ) restricted stock and restricted stock units the following table summarizes restricted stock and restricted stock unit activity for the fiscal year ended march 31 , 2012 : number of shares ( in thousands ) weighted average grant date fair value ( per share ) ."], "post_text": ["the remaining unrecognized compensation expense for outstanding restricted stock and restricted stock units , including performance-based awards , as of march 31 , 2012 was $ 7.1 million and the weighted-average period over which this cost will be recognized is 2.2 years .", "the weighted average grant-date fair value for restricted stock and restricted stock units granted during the years ended march 31 , 2012 , 2011 , and 2010 was $ 18.13 , $ 10.00 and $ 7.67 per share , respectively .", "the total fair value of restricted stock and restricted stock units vested in fiscal years 2012 , 2011 , and 2010 was $ 1.5 million , $ 1.0 million and $ 0.4 million , respectively .", "performance-based awards included in the restricted stock and restricted stock units activity discussed above are certain awards granted in fiscal years 2012 , 2011 and 2010 that vest subject to certain performance-based criteria .", "in june 2010 , 311000 shares of restricted stock and a performance-based award for the potential issuance of 45000 shares of common stock were issued to certain executive officers and members of senior management of the company , all of which would vest upon achievement of prescribed service milestones by the award recipients and performance milestones by the company .", "during the year ended march 31 , 2011 , the company determined that it met the prescribed performance targets and a portion of these shares and stock options vested .", "the remaining shares will vest upon satisfaction of prescribed service conditions by the award recipients .", "during the three months ended june 30 , 2011 , the company determined that it should have been using the graded vesting method instead of the straight-line method to expense stock-based compensation for the performance-based awards issued in june 2010 .", "this resulted in additional stock based compensation expense of approximately $ 0.6 million being recorded during the three months ended june 30 , 2011 that should have been recorded during the year ended march 31 , 2011 .", "the company believes that the amount is not material to its march 31 , 2011 consolidated financial statements and therefore recorded the adjustment in the quarter ended june 30 , 2011 .", "during the three months ended june 30 , 2011 , performance-based awards of restricted stock units for the potential issuance of 284000 shares of common stock were issued to certain executive officers and members of the senior management , all of which would vest upon achievement of prescribed service milestones by the award recipients and revenue performance milestones by the company .", "as of march 31 , 2012 , the company determined that it met the prescribed targets for 184000 shares underlying these awards and it believes it is probable that the prescribed performance targets will be met for the remaining 100000 shares , and the compensation expense is being recognized accordingly .", "during the year ended march 31 , 2012 , the company has recorded $ 3.3 million in stock-based compensation expense for equity awards in which the prescribed performance milestones have been achieved or are probable of being achieved .", "the remaining unrecognized compensation expense related to these equity awards at march 31 , 2012 is $ 3.6 million based on the company 2019s current assessment of probability of achieving the performance milestones .", "the weighted-average period over which this cost will be recognized is 2.1 years. ."], "table": [["", "number of shares ( in thousands )", "weighted average grant date fair value ( per share )"], ["restricted stock and restricted stock units at beginning of year", "407", "$ 9.84"], ["granted", "607", "18.13"], ["vested", "-134 ( 134 )", "10.88"], ["forfeited", "-9 ( 9 )", "13.72"], ["restricted stock and restricted stock units at end of year", "871", "$ 15.76"]], "table_ori": [["", "Number of Shares (in thousands)", "Weighted Average Grant Date Fair Value (per share)"], ["Restricted stock and restricted stock units at beginning of year", "407", "$9.84"], ["Granted", "607", "18.13"], ["Vested", "(134)", "10.88"], ["Forfeited", "(9)", "13.72"], ["Restricted stock and restricted stock units at end of year", "871", "$15.76"]]} | multiply(607, 18.13), multiply(#0, const_1000), multiply(3.3, const_1000000), greater(#1, #2) |
for equity awards where the performance criteria has been met in 2012 , what is the average compensation expense per year over which the cost will be expensed? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_75.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "1719526", "exe_answer": 1714285.71429} | {"text_16": "the remaining unrecognized compensation expense related to these equity awards at march 31 , 2012 is $ 3.6 million based on the company 2019s current assessment of probability of achieving the performance milestones .", "text_17": "the weighted-average period over which this cost will be recognized is 2.1 years. ."} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 8 .", "stock award plans and stock-based compensation ( continued ) restricted stock and restricted stock units the following table summarizes restricted stock and restricted stock unit activity for the fiscal year ended march 31 , 2012 : number of shares ( in thousands ) weighted average grant date fair value ( per share ) ."], "post_text": ["the remaining unrecognized compensation expense for outstanding restricted stock and restricted stock units , including performance-based awards , as of march 31 , 2012 was $ 7.1 million and the weighted-average period over which this cost will be recognized is 2.2 years .", "the weighted average grant-date fair value for restricted stock and restricted stock units granted during the years ended march 31 , 2012 , 2011 , and 2010 was $ 18.13 , $ 10.00 and $ 7.67 per share , respectively .", "the total fair value of restricted stock and restricted stock units vested in fiscal years 2012 , 2011 , and 2010 was $ 1.5 million , $ 1.0 million and $ 0.4 million , respectively .", "performance-based awards included in the restricted stock and restricted stock units activity discussed above are certain awards granted in fiscal years 2012 , 2011 and 2010 that vest subject to certain performance-based criteria .", "in june 2010 , 311000 shares of restricted stock and a performance-based award for the potential issuance of 45000 shares of common stock were issued to certain executive officers and members of senior management of the company , all of which would vest upon achievement of prescribed service milestones by the award recipients and performance milestones by the company .", "during the year ended march 31 , 2011 , the company determined that it met the prescribed performance targets and a portion of these shares and stock options vested .", "the remaining shares will vest upon satisfaction of prescribed service conditions by the award recipients .", "during the three months ended june 30 , 2011 , the company determined that it should have been using the graded vesting method instead of the straight-line method to expense stock-based compensation for the performance-based awards issued in june 2010 .", "this resulted in additional stock based compensation expense of approximately $ 0.6 million being recorded during the three months ended june 30 , 2011 that should have been recorded during the year ended march 31 , 2011 .", "the company believes that the amount is not material to its march 31 , 2011 consolidated financial statements and therefore recorded the adjustment in the quarter ended june 30 , 2011 .", "during the three months ended june 30 , 2011 , performance-based awards of restricted stock units for the potential issuance of 284000 shares of common stock were issued to certain executive officers and members of the senior management , all of which would vest upon achievement of prescribed service milestones by the award recipients and revenue performance milestones by the company .", "as of march 31 , 2012 , the company determined that it met the prescribed targets for 184000 shares underlying these awards and it believes it is probable that the prescribed performance targets will be met for the remaining 100000 shares , and the compensation expense is being recognized accordingly .", "during the year ended march 31 , 2012 , the company has recorded $ 3.3 million in stock-based compensation expense for equity awards in which the prescribed performance milestones have been achieved or are probable of being achieved .", "the remaining unrecognized compensation expense related to these equity awards at march 31 , 2012 is $ 3.6 million based on the company 2019s current assessment of probability of achieving the performance milestones .", "the weighted-average period over which this cost will be recognized is 2.1 years. ."], "table": [["", "number of shares ( in thousands )", "weighted average grant date fair value ( per share )"], ["restricted stock and restricted stock units at beginning of year", "407", "$ 9.84"], ["granted", "607", "18.13"], ["vested", "-134 ( 134 )", "10.88"], ["forfeited", "-9 ( 9 )", "13.72"], ["restricted stock and restricted stock units at end of year", "871", "$ 15.76"]], "table_ori": [["", "Number of Shares (in thousands)", "Weighted Average Grant Date Fair Value (per share)"], ["Restricted stock and restricted stock units at beginning of year", "407", "$9.84"], ["Granted", "607", "18.13"], ["Vested", "(134)", "10.88"], ["Forfeited", "(9)", "13.72"], ["Restricted stock and restricted stock units at end of year", "871", "$15.76"]]} | multiply(3.6, const_1000000), divide(#0, 2.1) |
what is the net change in the number of shares for restricted stock and restricted stock units during fiscal year ended march 31 , 2012? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_75.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "464", "exe_answer": 464.0} | {"table_1": "the restricted stock and restricted stock units at beginning of year of number of shares ( in thousands ) is 407 ; the restricted stock and restricted stock units at beginning of year of weighted average grant date fair value ( per share ) is $ 9.84 ;", "table_5": "the restricted stock and restricted stock units at end of year of number of shares ( in thousands ) is 871 ; the restricted stock and restricted stock units at end of year of weighted average grant date fair value ( per share ) is $ 15.76 ;"} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 8 .", "stock award plans and stock-based compensation ( continued ) restricted stock and restricted stock units the following table summarizes restricted stock and restricted stock unit activity for the fiscal year ended march 31 , 2012 : number of shares ( in thousands ) weighted average grant date fair value ( per share ) ."], "post_text": ["the remaining unrecognized compensation expense for outstanding restricted stock and restricted stock units , including performance-based awards , as of march 31 , 2012 was $ 7.1 million and the weighted-average period over which this cost will be recognized is 2.2 years .", "the weighted average grant-date fair value for restricted stock and restricted stock units granted during the years ended march 31 , 2012 , 2011 , and 2010 was $ 18.13 , $ 10.00 and $ 7.67 per share , respectively .", "the total fair value of restricted stock and restricted stock units vested in fiscal years 2012 , 2011 , and 2010 was $ 1.5 million , $ 1.0 million and $ 0.4 million , respectively .", "performance-based awards included in the restricted stock and restricted stock units activity discussed above are certain awards granted in fiscal years 2012 , 2011 and 2010 that vest subject to certain performance-based criteria .", "in june 2010 , 311000 shares of restricted stock and a performance-based award for the potential issuance of 45000 shares of common stock were issued to certain executive officers and members of senior management of the company , all of which would vest upon achievement of prescribed service milestones by the award recipients and performance milestones by the company .", "during the year ended march 31 , 2011 , the company determined that it met the prescribed performance targets and a portion of these shares and stock options vested .", "the remaining shares will vest upon satisfaction of prescribed service conditions by the award recipients .", "during the three months ended june 30 , 2011 , the company determined that it should have been using the graded vesting method instead of the straight-line method to expense stock-based compensation for the performance-based awards issued in june 2010 .", "this resulted in additional stock based compensation expense of approximately $ 0.6 million being recorded during the three months ended june 30 , 2011 that should have been recorded during the year ended march 31 , 2011 .", "the company believes that the amount is not material to its march 31 , 2011 consolidated financial statements and therefore recorded the adjustment in the quarter ended june 30 , 2011 .", "during the three months ended june 30 , 2011 , performance-based awards of restricted stock units for the potential issuance of 284000 shares of common stock were issued to certain executive officers and members of the senior management , all of which would vest upon achievement of prescribed service milestones by the award recipients and revenue performance milestones by the company .", "as of march 31 , 2012 , the company determined that it met the prescribed targets for 184000 shares underlying these awards and it believes it is probable that the prescribed performance targets will be met for the remaining 100000 shares , and the compensation expense is being recognized accordingly .", "during the year ended march 31 , 2012 , the company has recorded $ 3.3 million in stock-based compensation expense for equity awards in which the prescribed performance milestones have been achieved or are probable of being achieved .", "the remaining unrecognized compensation expense related to these equity awards at march 31 , 2012 is $ 3.6 million based on the company 2019s current assessment of probability of achieving the performance milestones .", "the weighted-average period over which this cost will be recognized is 2.1 years. ."], "table": [["", "number of shares ( in thousands )", "weighted average grant date fair value ( per share )"], ["restricted stock and restricted stock units at beginning of year", "407", "$ 9.84"], ["granted", "607", "18.13"], ["vested", "-134 ( 134 )", "10.88"], ["forfeited", "-9 ( 9 )", "13.72"], ["restricted stock and restricted stock units at end of year", "871", "$ 15.76"]], "table_ori": [["", "Number of Shares (in thousands)", "Weighted Average Grant Date Fair Value (per share)"], ["Restricted stock and restricted stock units at beginning of year", "407", "$9.84"], ["Granted", "607", "18.13"], ["Vested", "(134)", "10.88"], ["Forfeited", "(9)", "13.72"], ["Restricted stock and restricted stock units at end of year", "871", "$15.76"]]} | subtract(871, 407) |
what is the total value of vested shares during the fiscal year ended march 31 , 2012 , in millions? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_75.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "1.46", "exe_answer": 1.45792} | {"table_3": "the vested of number of shares ( in thousands ) is -134 ( 134 ) ; the vested of weighted average grant date fair value ( per share ) is 10.88 ;"} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 8 .", "stock award plans and stock-based compensation ( continued ) restricted stock and restricted stock units the following table summarizes restricted stock and restricted stock unit activity for the fiscal year ended march 31 , 2012 : number of shares ( in thousands ) weighted average grant date fair value ( per share ) ."], "post_text": ["the remaining unrecognized compensation expense for outstanding restricted stock and restricted stock units , including performance-based awards , as of march 31 , 2012 was $ 7.1 million and the weighted-average period over which this cost will be recognized is 2.2 years .", "the weighted average grant-date fair value for restricted stock and restricted stock units granted during the years ended march 31 , 2012 , 2011 , and 2010 was $ 18.13 , $ 10.00 and $ 7.67 per share , respectively .", "the total fair value of restricted stock and restricted stock units vested in fiscal years 2012 , 2011 , and 2010 was $ 1.5 million , $ 1.0 million and $ 0.4 million , respectively .", "performance-based awards included in the restricted stock and restricted stock units activity discussed above are certain awards granted in fiscal years 2012 , 2011 and 2010 that vest subject to certain performance-based criteria .", "in june 2010 , 311000 shares of restricted stock and a performance-based award for the potential issuance of 45000 shares of common stock were issued to certain executive officers and members of senior management of the company , all of which would vest upon achievement of prescribed service milestones by the award recipients and performance milestones by the company .", "during the year ended march 31 , 2011 , the company determined that it met the prescribed performance targets and a portion of these shares and stock options vested .", "the remaining shares will vest upon satisfaction of prescribed service conditions by the award recipients .", "during the three months ended june 30 , 2011 , the company determined that it should have been using the graded vesting method instead of the straight-line method to expense stock-based compensation for the performance-based awards issued in june 2010 .", "this resulted in additional stock based compensation expense of approximately $ 0.6 million being recorded during the three months ended june 30 , 2011 that should have been recorded during the year ended march 31 , 2011 .", "the company believes that the amount is not material to its march 31 , 2011 consolidated financial statements and therefore recorded the adjustment in the quarter ended june 30 , 2011 .", "during the three months ended june 30 , 2011 , performance-based awards of restricted stock units for the potential issuance of 284000 shares of common stock were issued to certain executive officers and members of the senior management , all of which would vest upon achievement of prescribed service milestones by the award recipients and revenue performance milestones by the company .", "as of march 31 , 2012 , the company determined that it met the prescribed targets for 184000 shares underlying these awards and it believes it is probable that the prescribed performance targets will be met for the remaining 100000 shares , and the compensation expense is being recognized accordingly .", "during the year ended march 31 , 2012 , the company has recorded $ 3.3 million in stock-based compensation expense for equity awards in which the prescribed performance milestones have been achieved or are probable of being achieved .", "the remaining unrecognized compensation expense related to these equity awards at march 31 , 2012 is $ 3.6 million based on the company 2019s current assessment of probability of achieving the performance milestones .", "the weighted-average period over which this cost will be recognized is 2.1 years. ."], "table": [["", "number of shares ( in thousands )", "weighted average grant date fair value ( per share )"], ["restricted stock and restricted stock units at beginning of year", "407", "$ 9.84"], ["granted", "607", "18.13"], ["vested", "-134 ( 134 )", "10.88"], ["forfeited", "-9 ( 9 )", "13.72"], ["restricted stock and restricted stock units at end of year", "871", "$ 15.76"]], "table_ori": [["", "Number of Shares (in thousands)", "Weighted Average Grant Date Fair Value (per share)"], ["Restricted stock and restricted stock units at beginning of year", "407", "$9.84"], ["Granted", "607", "18.13"], ["Vested", "(134)", "10.88"], ["Forfeited", "(9)", "13.72"], ["Restricted stock and restricted stock units at end of year", "871", "$15.76"]]} | multiply(134, 10.88), divide(#0, const_1000) |
did abiomed outperform the nasdaq medical equipment index? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_41.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "yes", "exe_answer": "yes"} | {"table_1": "the abiomed inc of 3/31/2007 is 100 ; the abiomed inc of 3/31/2008 is 96.19 ; the abiomed inc of 3/31/2009 is 35.87 ; the abiomed inc of 3/31/2010 is 75.55 ; the abiomed inc of 3/31/2011 is 106.37 ; the abiomed inc of 3/31/2012 is 162.45 ;", "table_3": "the nasdaq medical equipment sic code 3840-3849 of 3/31/2007 is 100 ; the nasdaq medical equipment sic code 3840-3849 of 3/31/2008 is 82.91 ; the nasdaq medical equipment sic code 3840-3849 of 3/31/2009 is 41.56 ; the nasdaq medical equipment sic code 3840-3849 of 3/31/2010 is 77.93 ; the nasdaq medical equipment sic code 3840-3849 of 3/31/2011 is 94.54 ; the nasdaq medical equipment sic code 3840-3849 of 3/31/2012 is 74.40 ;"} | {"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2007 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["abiomed inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["nasdaq composite index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["nasdaq medical equipment sic code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]], "table_ori": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["ABIOMED, Inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["Nasdaq Composite Index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]]} | greater(162.45, 74.40) |
did abiomed outperform the nasdaq composite index? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_41.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "yes", "exe_answer": "yes"} | {"table_1": "the abiomed inc of 3/31/2007 is 100 ; the abiomed inc of 3/31/2008 is 96.19 ; the abiomed inc of 3/31/2009 is 35.87 ; the abiomed inc of 3/31/2010 is 75.55 ; the abiomed inc of 3/31/2011 is 106.37 ; the abiomed inc of 3/31/2012 is 162.45 ;", "table_2": "the nasdaq composite index of 3/31/2007 is 100 ; the nasdaq composite index of 3/31/2008 is 94.11 ; the nasdaq composite index of 3/31/2009 is 63.12 ; the nasdaq composite index of 3/31/2010 is 99.02 ; the nasdaq composite index of 3/31/2011 is 114.84 ; the nasdaq composite index of 3/31/2012 is 127.66 ;"} | {"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2007 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["abiomed inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["nasdaq composite index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["nasdaq medical equipment sic code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]], "table_ori": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["ABIOMED, Inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["Nasdaq Composite Index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]]} | greater(162.45, 127.66) |
what was total rent expense for fiscal years 2010 to 2012 , in millions? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_79.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "6.6", "exe_answer": 6.5} | {"text_26": "total rent expense for the company 2019s operating leases included in the accompanying consolidated statements of operations approximated $ 1.6 million , $ 2.7 million and $ 2.2 million for the fiscal years ended march 31 , 2012 , 2011 , and 2010 , respectively ."} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 10 .", "commitments and contingencies the following is a description of the company 2019s significant arrangements in which the company is a guarantor .", "indemnifications 2014in many sales transactions , the company indemnifies customers against possible claims of patent infringement caused by the company 2019s products .", "the indemnifications contained within sales contracts usually do not include limits on the claims .", "the company has never incurred any material costs to defend lawsuits or settle patent infringement claims related to sales transactions .", "the company enters into agreements with other companies in the ordinary course of business , typically with underwriters , contractors , clinical sites and customers that include indemnification provisions .", "under these provisions the company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of its activities .", "these indemnification provisions generally survive termination of the underlying agreement .", "the maximum potential amount of future payments the company could be required to make under these indemnification provisions is unlimited .", "abiomed has never incurred any material costs to defend lawsuits or settle claims related to these indemnification agreements .", "as a result , the estimated fair value of these agreements is immaterial .", "accordingly , the company has no liabilities recorded for these agreements as of march 31 , 2012 .", "clinical study agreements 2014in the company 2019s clinical study agreements , abiomed has agreed to indemnify the participating institutions against losses incurred by them for claims related to any personal injury of subjects taking part in the study to the extent they relate to uses of the company 2019s devices in accordance with the clinical study agreement , the protocol for the device and abiomed 2019s instructions .", "the indemnification provisions contained within the company 2019s clinical study agreements do not generally include limits on the claims .", "the company has never incurred any material costs related to the indemnification provisions contained in its clinical study agreements .", "facilities leases 2014the company rents its danvers , massachusetts facility under an operating lease agreement that expires on february 28 , 2016 .", "monthly rent under the facility lease is as follows : 2022 the base rent for november 2008 through june 2010 was $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 is $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month .", "in addition , the company has certain rights to terminate the facility lease early , subject to the payment of a specified termination fee based on the timing of the termination , as further outlined in the lease amendment .", "the company has a lease for its european headquarters in aachen , germany .", "the lease payments are approximately 36000 20ac ( euro ) ( approximately u.s .", "$ 50000 at march 31 , 2012 exchange rates ) per month and the lease term expires in december 2012 .", "in july 2008 , the company entered into a lease agreement providing for the lease of a 33000 square foot manufacturing facility in athlone , ireland .", "the lease agreement was for a term of 25 years , commencing on july 18 , 2008 .", "the company relocated the production equipment from its athlone , ireland manufacturing facility to its aachen and danvers facilities and fully vacated the athlone facility in the first quarter of fiscal 2011 .", "in march 2011 , the company terminated the lease agreement and paid a termination fee of approximately $ 0.8 million as a result of the early termination of the lease .", "total rent expense for the company 2019s operating leases included in the accompanying consolidated statements of operations approximated $ 1.6 million , $ 2.7 million and $ 2.2 million for the fiscal years ended march 31 , 2012 , 2011 , and 2010 , respectively .", "future minimum lease payments under all significant non-cancelable operating leases as of march 31 , 2012 are approximately as follows : fiscal year ending march 31 , operating leases ( in $ 000s ) ."], "post_text": ["."], "table": [["fiscal year ending march 31,", "operating leases ( in $ 000s )"], ["2013", "1473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["thereafter", "128"], ["total future minimum lease payments", "$ 4218"]], "table_ori": [["Fiscal Year Ending March 31,", "Operating Leases (in $000s)"], ["2013", "1,473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["Thereafter", "128"], ["Total future minimum lease payments", "$4,218"]]} | add(1.6, 2.7), add(2.2, #0) |
how much of total future minimum lease payments are due currently? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_79.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "35%", "exe_answer": 2845.5} | {"table_7": "fiscal year ending march 31 , the total future minimum lease payments of operating leases ( in $ 000s ) is $ 4218 ;", "table_1": "fiscal year ending march 31 , the 2013 of operating leases ( in $ 000s ) is 1473 ;"} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 10 .", "commitments and contingencies the following is a description of the company 2019s significant arrangements in which the company is a guarantor .", "indemnifications 2014in many sales transactions , the company indemnifies customers against possible claims of patent infringement caused by the company 2019s products .", "the indemnifications contained within sales contracts usually do not include limits on the claims .", "the company has never incurred any material costs to defend lawsuits or settle patent infringement claims related to sales transactions .", "the company enters into agreements with other companies in the ordinary course of business , typically with underwriters , contractors , clinical sites and customers that include indemnification provisions .", "under these provisions the company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of its activities .", "these indemnification provisions generally survive termination of the underlying agreement .", "the maximum potential amount of future payments the company could be required to make under these indemnification provisions is unlimited .", "abiomed has never incurred any material costs to defend lawsuits or settle claims related to these indemnification agreements .", "as a result , the estimated fair value of these agreements is immaterial .", "accordingly , the company has no liabilities recorded for these agreements as of march 31 , 2012 .", "clinical study agreements 2014in the company 2019s clinical study agreements , abiomed has agreed to indemnify the participating institutions against losses incurred by them for claims related to any personal injury of subjects taking part in the study to the extent they relate to uses of the company 2019s devices in accordance with the clinical study agreement , the protocol for the device and abiomed 2019s instructions .", "the indemnification provisions contained within the company 2019s clinical study agreements do not generally include limits on the claims .", "the company has never incurred any material costs related to the indemnification provisions contained in its clinical study agreements .", "facilities leases 2014the company rents its danvers , massachusetts facility under an operating lease agreement that expires on february 28 , 2016 .", "monthly rent under the facility lease is as follows : 2022 the base rent for november 2008 through june 2010 was $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 is $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month .", "in addition , the company has certain rights to terminate the facility lease early , subject to the payment of a specified termination fee based on the timing of the termination , as further outlined in the lease amendment .", "the company has a lease for its european headquarters in aachen , germany .", "the lease payments are approximately 36000 20ac ( euro ) ( approximately u.s .", "$ 50000 at march 31 , 2012 exchange rates ) per month and the lease term expires in december 2012 .", "in july 2008 , the company entered into a lease agreement providing for the lease of a 33000 square foot manufacturing facility in athlone , ireland .", "the lease agreement was for a term of 25 years , commencing on july 18 , 2008 .", "the company relocated the production equipment from its athlone , ireland manufacturing facility to its aachen and danvers facilities and fully vacated the athlone facility in the first quarter of fiscal 2011 .", "in march 2011 , the company terminated the lease agreement and paid a termination fee of approximately $ 0.8 million as a result of the early termination of the lease .", "total rent expense for the company 2019s operating leases included in the accompanying consolidated statements of operations approximated $ 1.6 million , $ 2.7 million and $ 2.2 million for the fiscal years ended march 31 , 2012 , 2011 , and 2010 , respectively .", "future minimum lease payments under all significant non-cancelable operating leases as of march 31 , 2012 are approximately as follows : fiscal year ending march 31 , operating leases ( in $ 000s ) ."], "post_text": ["."], "table": [["fiscal year ending march 31,", "operating leases ( in $ 000s )"], ["2013", "1473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["thereafter", "128"], ["total future minimum lease payments", "$ 4218"]], "table_ori": [["Fiscal Year Ending March 31,", "Operating Leases (in $000s)"], ["2013", "1,473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["Thereafter", "128"], ["Total future minimum lease payments", "$4,218"]]} | add(1473, 4218), divide(#0, const_2) |
what is the percentage increase in base rent for danvers , massachusetts facility from the period 2008-2010 to 2010 - 2014? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_79.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "60.9%", "exe_answer": 0.60875} | {"text_17": "monthly rent under the facility lease is as follows : 2022 the base rent for november 2008 through june 2010 was $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 is $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month ."} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 10 .", "commitments and contingencies the following is a description of the company 2019s significant arrangements in which the company is a guarantor .", "indemnifications 2014in many sales transactions , the company indemnifies customers against possible claims of patent infringement caused by the company 2019s products .", "the indemnifications contained within sales contracts usually do not include limits on the claims .", "the company has never incurred any material costs to defend lawsuits or settle patent infringement claims related to sales transactions .", "the company enters into agreements with other companies in the ordinary course of business , typically with underwriters , contractors , clinical sites and customers that include indemnification provisions .", "under these provisions the company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of its activities .", "these indemnification provisions generally survive termination of the underlying agreement .", "the maximum potential amount of future payments the company could be required to make under these indemnification provisions is unlimited .", "abiomed has never incurred any material costs to defend lawsuits or settle claims related to these indemnification agreements .", "as a result , the estimated fair value of these agreements is immaterial .", "accordingly , the company has no liabilities recorded for these agreements as of march 31 , 2012 .", "clinical study agreements 2014in the company 2019s clinical study agreements , abiomed has agreed to indemnify the participating institutions against losses incurred by them for claims related to any personal injury of subjects taking part in the study to the extent they relate to uses of the company 2019s devices in accordance with the clinical study agreement , the protocol for the device and abiomed 2019s instructions .", "the indemnification provisions contained within the company 2019s clinical study agreements do not generally include limits on the claims .", "the company has never incurred any material costs related to the indemnification provisions contained in its clinical study agreements .", "facilities leases 2014the company rents its danvers , massachusetts facility under an operating lease agreement that expires on february 28 , 2016 .", "monthly rent under the facility lease is as follows : 2022 the base rent for november 2008 through june 2010 was $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 is $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month .", "in addition , the company has certain rights to terminate the facility lease early , subject to the payment of a specified termination fee based on the timing of the termination , as further outlined in the lease amendment .", "the company has a lease for its european headquarters in aachen , germany .", "the lease payments are approximately 36000 20ac ( euro ) ( approximately u.s .", "$ 50000 at march 31 , 2012 exchange rates ) per month and the lease term expires in december 2012 .", "in july 2008 , the company entered into a lease agreement providing for the lease of a 33000 square foot manufacturing facility in athlone , ireland .", "the lease agreement was for a term of 25 years , commencing on july 18 , 2008 .", "the company relocated the production equipment from its athlone , ireland manufacturing facility to its aachen and danvers facilities and fully vacated the athlone facility in the first quarter of fiscal 2011 .", "in march 2011 , the company terminated the lease agreement and paid a termination fee of approximately $ 0.8 million as a result of the early termination of the lease .", "total rent expense for the company 2019s operating leases included in the accompanying consolidated statements of operations approximated $ 1.6 million , $ 2.7 million and $ 2.2 million for the fiscal years ended march 31 , 2012 , 2011 , and 2010 , respectively .", "future minimum lease payments under all significant non-cancelable operating leases as of march 31 , 2012 are approximately as follows : fiscal year ending march 31 , operating leases ( in $ 000s ) ."], "post_text": ["."], "table": [["fiscal year ending march 31,", "operating leases ( in $ 000s )"], ["2013", "1473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["thereafter", "128"], ["total future minimum lease payments", "$ 4218"]], "table_ori": [["Fiscal Year Ending March 31,", "Operating Leases (in $000s)"], ["2013", "1,473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["Thereafter", "128"], ["Total future minimum lease payments", "$4,218"]]} | subtract(64350, 40000), divide(#0, 40000) |
what is the percentage increase in base rent for danvers , massachusetts facility from the period 2010-2014 to 2014-2016? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_79.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "2.6%", "exe_answer": 0.02564} | {"text_17": "monthly rent under the facility lease is as follows : 2022 the base rent for november 2008 through june 2010 was $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 is $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month ."} | {"pre_text": ["abiomed , inc .", "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 10 .", "commitments and contingencies the following is a description of the company 2019s significant arrangements in which the company is a guarantor .", "indemnifications 2014in many sales transactions , the company indemnifies customers against possible claims of patent infringement caused by the company 2019s products .", "the indemnifications contained within sales contracts usually do not include limits on the claims .", "the company has never incurred any material costs to defend lawsuits or settle patent infringement claims related to sales transactions .", "the company enters into agreements with other companies in the ordinary course of business , typically with underwriters , contractors , clinical sites and customers that include indemnification provisions .", "under these provisions the company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of its activities .", "these indemnification provisions generally survive termination of the underlying agreement .", "the maximum potential amount of future payments the company could be required to make under these indemnification provisions is unlimited .", "abiomed has never incurred any material costs to defend lawsuits or settle claims related to these indemnification agreements .", "as a result , the estimated fair value of these agreements is immaterial .", "accordingly , the company has no liabilities recorded for these agreements as of march 31 , 2012 .", "clinical study agreements 2014in the company 2019s clinical study agreements , abiomed has agreed to indemnify the participating institutions against losses incurred by them for claims related to any personal injury of subjects taking part in the study to the extent they relate to uses of the company 2019s devices in accordance with the clinical study agreement , the protocol for the device and abiomed 2019s instructions .", "the indemnification provisions contained within the company 2019s clinical study agreements do not generally include limits on the claims .", "the company has never incurred any material costs related to the indemnification provisions contained in its clinical study agreements .", "facilities leases 2014the company rents its danvers , massachusetts facility under an operating lease agreement that expires on february 28 , 2016 .", "monthly rent under the facility lease is as follows : 2022 the base rent for november 2008 through june 2010 was $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 is $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month .", "in addition , the company has certain rights to terminate the facility lease early , subject to the payment of a specified termination fee based on the timing of the termination , as further outlined in the lease amendment .", "the company has a lease for its european headquarters in aachen , germany .", "the lease payments are approximately 36000 20ac ( euro ) ( approximately u.s .", "$ 50000 at march 31 , 2012 exchange rates ) per month and the lease term expires in december 2012 .", "in july 2008 , the company entered into a lease agreement providing for the lease of a 33000 square foot manufacturing facility in athlone , ireland .", "the lease agreement was for a term of 25 years , commencing on july 18 , 2008 .", "the company relocated the production equipment from its athlone , ireland manufacturing facility to its aachen and danvers facilities and fully vacated the athlone facility in the first quarter of fiscal 2011 .", "in march 2011 , the company terminated the lease agreement and paid a termination fee of approximately $ 0.8 million as a result of the early termination of the lease .", "total rent expense for the company 2019s operating leases included in the accompanying consolidated statements of operations approximated $ 1.6 million , $ 2.7 million and $ 2.2 million for the fiscal years ended march 31 , 2012 , 2011 , and 2010 , respectively .", "future minimum lease payments under all significant non-cancelable operating leases as of march 31 , 2012 are approximately as follows : fiscal year ending march 31 , operating leases ( in $ 000s ) ."], "post_text": ["."], "table": [["fiscal year ending march 31,", "operating leases ( in $ 000s )"], ["2013", "1473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["thereafter", "128"], ["total future minimum lease payments", "$ 4218"]], "table_ori": [["Fiscal Year Ending March 31,", "Operating Leases (in $000s)"], ["2013", "1,473"], ["2014", "964"], ["2015", "863"], ["2016", "758"], ["2017", "32"], ["Thereafter", "128"], ["Total future minimum lease payments", "$4,218"]]} | subtract(66000, 64350), divide(#0, 64350) |
what is the roi of an investment in abiomed inc from march 2007 to march 2010? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_41.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "-24.5%", "exe_answer": -0.2445} | {"table_1": "the abiomed inc of 3/31/2007 is 100 ; the abiomed inc of 3/31/2008 is 96.19 ; the abiomed inc of 3/31/2009 is 35.87 ; the abiomed inc of 3/31/2010 is 75.55 ; the abiomed inc of 3/31/2011 is 106.37 ; the abiomed inc of 3/31/2012 is 162.45 ;"} | {"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2007 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["abiomed inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["nasdaq composite index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["nasdaq medical equipment sic code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]], "table_ori": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["ABIOMED, Inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["Nasdaq Composite Index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]]} | subtract(75.55, 100), divide(#0, 100) |
what is the roi of an investment in nasdaq composite index from march 2007 to march 2010? | {"label_key": "ABMD_2012", "label_file": "fin_qa", "q_uid": "ABMD/2012/page_41.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "-1.0%", "exe_answer": -0.0098} | {"table_2": "the nasdaq composite index of 3/31/2007 is 100 ; the nasdaq composite index of 3/31/2008 is 94.11 ; the nasdaq composite index of 3/31/2009 is 63.12 ; the nasdaq composite index of 3/31/2010 is 99.02 ; the nasdaq composite index of 3/31/2011 is 114.84 ; the nasdaq composite index of 3/31/2012 is 127.66 ;"} | {"pre_text": ["performance graph the following graph compares the yearly change in the cumulative total stockholder return for our last five full fiscal years , based upon the market price of our common stock , with the cumulative total return on a nasdaq composite index ( u.s .", "companies ) and a peer group , the nasdaq medical equipment-sic code 3840-3849 index , which is comprised of medical equipment companies , for that period .", "the performance graph assumes the investment of $ 100 on march 31 , 2007 in our common stock , the nasdaq composite index ( u.s .", "companies ) and the peer group index , and the reinvestment of any and all dividends. ."], "post_text": ["this graph is not 201csoliciting material 201d under regulation 14a or 14c of the rules promulgated under the securities exchange act of 1934 , is not deemed filed with the securities and exchange commission and is not to be incorporated by reference in any of our filings under the securities act of 1933 , as amended , or the exchange act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing .", "transfer agent american stock transfer & trust company , 59 maiden lane , new york , ny 10038 , is our stock transfer agent. ."], "table": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["abiomed inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["nasdaq composite index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["nasdaq medical equipment sic code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]], "table_ori": [["", "3/31/2007", "3/31/2008", "3/31/2009", "3/31/2010", "3/31/2011", "3/31/2012"], ["ABIOMED, Inc", "100", "96.19", "35.87", "75.55", "106.37", "162.45"], ["Nasdaq Composite Index", "100", "94.11", "63.12", "99.02", "114.84", "127.66"], ["Nasdaq Medical Equipment SIC Code 3840-3849", "100", "82.91", "41.56", "77.93", "94.54", "74.40"]]} | subtract(99.02, 100), divide(#0, 100) |
what was the total operating expenses in 2018 in millions | {"label_key": "AAL_2018", "label_file": "fin_qa", "q_uid": "AAL/2018/page_13.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "41932", "exe_answer": 41932.20339} | {"table_1": "year the 2018 of gallons is 4447 ; the 2018 of average priceper gallon is $ 2.23 ; the 2018 of aircraft fuelexpense is $ 9896 ; the 2018 of percent of totaloperating expenses is 23.6% ( 23.6 % ) ;"} | {"pre_text": ["the following table shows annual aircraft fuel consumption and costs , including taxes , for our mainline and regional operations for 2018 , 2017 and 2016 ( gallons and aircraft fuel expense in millions ) .", "year gallons average price per gallon aircraft fuel expense percent of total operating expenses ."], "post_text": ["as of december 31 , 2018 , we did not have any fuel hedging contracts outstanding to hedge our fuel consumption .", "as such , and assuming we do not enter into any future transactions to hedge our fuel consumption , we will continue to be fully exposed to fluctuations in fuel prices .", "our current policy is not to enter into transactions to hedge our fuel consumption , although we review that policy from time to time based on market conditions and other factors .", "fuel prices have fluctuated substantially over the past several years .", "we cannot predict the future availability , price volatility or cost of aircraft fuel .", "natural disasters ( including hurricanes or similar events in the u.s .", "southeast and on the gulf coast where a significant portion of domestic refining capacity is located ) , political disruptions or wars involving oil-producing countries , economic sanctions imposed against oil-producing countries or specific industry participants , changes in fuel-related governmental policy , the strength of the u.s .", "dollar against foreign currencies , changes in the cost to transport or store petroleum products , changes in access to petroleum product pipelines and terminals , speculation in the energy futures markets , changes in aircraft fuel production capacity , environmental concerns and other unpredictable events may result in fuel supply shortages , distribution challenges , additional fuel price volatility and cost increases in the future .", "see part i , item 1a .", "risk factors 2013 201cour business is very dependent on the price and availability of aircraft fuel .", "continued periods of high volatility in fuel costs , increased fuel prices or significant disruptions in the supply of aircraft fuel could have a significant negative impact on our operating results and liquidity . 201d seasonality and other factors due to the greater demand for air travel during the summer months , revenues in the airline industry in the second and third quarters of the year tend to be greater than revenues in the first and fourth quarters of the year .", "general economic conditions , fears of terrorism or war , fare initiatives , fluctuations in fuel prices , labor actions , weather , natural disasters , outbreaks of disease and other factors could impact this seasonal pattern .", "therefore , our quarterly results of operations are not necessarily indicative of operating results for the entire year , and historical operating results in a quarterly or annual period are not necessarily indicative of future operating results .", "domestic and global regulatory landscape general airlines are subject to extensive domestic and international regulatory requirements .", "domestically , the dot and the federal aviation administration ( faa ) exercise significant regulatory authority over air carriers .", "the dot , among other things , oversees domestic and international codeshare agreements , international route authorities , competition and consumer protection matters such as advertising , denied boarding compensation and baggage liability .", "the antitrust division of the department of justice ( doj ) , along with the dot in certain instances , have jurisdiction over airline antitrust matters. ."], "table": [["year", "gallons", "average priceper gallon", "aircraft fuelexpense", "percent of totaloperating expenses"], ["2018", "4447", "$ 2.23", "$ 9896", "23.6% ( 23.6 % )"], ["2017", "4352", "1.73", "7510", "19.6% ( 19.6 % )"], ["2016", "4347", "1.42", "6180", "17.6% ( 17.6 % )"]], "table_ori": [["Year", "Gallons", "Average Priceper Gallon", "Aircraft FuelExpense", "Percent of TotalOperating Expenses"], ["2018", "4,447", "$2.23", "$9,896", "23.6%"], ["2017", "4,352", "1.73", "7,510", "19.6%"], ["2016", "4,347", "1.42", "6,180", "17.6%"]]} | divide(9896, 23.6%) |
what were total operating expenses in 2018? | {"label_key": "AAL_2018", "label_file": "fin_qa", "q_uid": "AAL/2018/page_13.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "41932", "exe_answer": 41932.20339} | {"table_1": "year the 2018 of gallons is 4447 ; the 2018 of average priceper gallon is $ 2.23 ; the 2018 of aircraft fuelexpense is $ 9896 ; the 2018 of percent of totaloperating expenses is 23.6% ( 23.6 % ) ;"} | {"pre_text": ["the following table shows annual aircraft fuel consumption and costs , including taxes , for our mainline and regional operations for 2018 , 2017 and 2016 ( gallons and aircraft fuel expense in millions ) .", "year gallons average price per gallon aircraft fuel expense percent of total operating expenses ."], "post_text": ["as of december 31 , 2018 , we did not have any fuel hedging contracts outstanding to hedge our fuel consumption .", "as such , and assuming we do not enter into any future transactions to hedge our fuel consumption , we will continue to be fully exposed to fluctuations in fuel prices .", "our current policy is not to enter into transactions to hedge our fuel consumption , although we review that policy from time to time based on market conditions and other factors .", "fuel prices have fluctuated substantially over the past several years .", "we cannot predict the future availability , price volatility or cost of aircraft fuel .", "natural disasters ( including hurricanes or similar events in the u.s .", "southeast and on the gulf coast where a significant portion of domestic refining capacity is located ) , political disruptions or wars involving oil-producing countries , economic sanctions imposed against oil-producing countries or specific industry participants , changes in fuel-related governmental policy , the strength of the u.s .", "dollar against foreign currencies , changes in the cost to transport or store petroleum products , changes in access to petroleum product pipelines and terminals , speculation in the energy futures markets , changes in aircraft fuel production capacity , environmental concerns and other unpredictable events may result in fuel supply shortages , distribution challenges , additional fuel price volatility and cost increases in the future .", "see part i , item 1a .", "risk factors 2013 201cour business is very dependent on the price and availability of aircraft fuel .", "continued periods of high volatility in fuel costs , increased fuel prices or significant disruptions in the supply of aircraft fuel could have a significant negative impact on our operating results and liquidity . 201d seasonality and other factors due to the greater demand for air travel during the summer months , revenues in the airline industry in the second and third quarters of the year tend to be greater than revenues in the first and fourth quarters of the year .", "general economic conditions , fears of terrorism or war , fare initiatives , fluctuations in fuel prices , labor actions , weather , natural disasters , outbreaks of disease and other factors could impact this seasonal pattern .", "therefore , our quarterly results of operations are not necessarily indicative of operating results for the entire year , and historical operating results in a quarterly or annual period are not necessarily indicative of future operating results .", "domestic and global regulatory landscape general airlines are subject to extensive domestic and international regulatory requirements .", "domestically , the dot and the federal aviation administration ( faa ) exercise significant regulatory authority over air carriers .", "the dot , among other things , oversees domestic and international codeshare agreements , international route authorities , competition and consumer protection matters such as advertising , denied boarding compensation and baggage liability .", "the antitrust division of the department of justice ( doj ) , along with the dot in certain instances , have jurisdiction over airline antitrust matters. ."], "table": [["year", "gallons", "average priceper gallon", "aircraft fuelexpense", "percent of totaloperating expenses"], ["2018", "4447", "$ 2.23", "$ 9896", "23.6% ( 23.6 % )"], ["2017", "4352", "1.73", "7510", "19.6% ( 19.6 % )"], ["2016", "4347", "1.42", "6180", "17.6% ( 17.6 % )"]], "table_ori": [["Year", "Gallons", "Average Priceper Gallon", "Aircraft FuelExpense", "Percent of TotalOperating Expenses"], ["2018", "4,447", "$2.23", "$9,896", "23.6%"], ["2017", "4,352", "1.73", "7,510", "19.6%"], ["2016", "4,347", "1.42", "6,180", "17.6%"]]} | divide(9896, 23.6%) |
what were total operating expenses in 2017? | {"label_key": "AAL_2018", "label_file": "fin_qa", "q_uid": "AAL/2018/page_13.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "38316\\\\n", "exe_answer": 38316.32653} | {"table_2": "year the 2017 of gallons is 4352 ; the 2017 of average priceper gallon is 1.73 ; the 2017 of aircraft fuelexpense is 7510 ; the 2017 of percent of totaloperating expenses is 19.6% ( 19.6 % ) ;"} | {"pre_text": ["the following table shows annual aircraft fuel consumption and costs , including taxes , for our mainline and regional operations for 2018 , 2017 and 2016 ( gallons and aircraft fuel expense in millions ) .", "year gallons average price per gallon aircraft fuel expense percent of total operating expenses ."], "post_text": ["as of december 31 , 2018 , we did not have any fuel hedging contracts outstanding to hedge our fuel consumption .", "as such , and assuming we do not enter into any future transactions to hedge our fuel consumption , we will continue to be fully exposed to fluctuations in fuel prices .", "our current policy is not to enter into transactions to hedge our fuel consumption , although we review that policy from time to time based on market conditions and other factors .", "fuel prices have fluctuated substantially over the past several years .", "we cannot predict the future availability , price volatility or cost of aircraft fuel .", "natural disasters ( including hurricanes or similar events in the u.s .", "southeast and on the gulf coast where a significant portion of domestic refining capacity is located ) , political disruptions or wars involving oil-producing countries , economic sanctions imposed against oil-producing countries or specific industry participants , changes in fuel-related governmental policy , the strength of the u.s .", "dollar against foreign currencies , changes in the cost to transport or store petroleum products , changes in access to petroleum product pipelines and terminals , speculation in the energy futures markets , changes in aircraft fuel production capacity , environmental concerns and other unpredictable events may result in fuel supply shortages , distribution challenges , additional fuel price volatility and cost increases in the future .", "see part i , item 1a .", "risk factors 2013 201cour business is very dependent on the price and availability of aircraft fuel .", "continued periods of high volatility in fuel costs , increased fuel prices or significant disruptions in the supply of aircraft fuel could have a significant negative impact on our operating results and liquidity . 201d seasonality and other factors due to the greater demand for air travel during the summer months , revenues in the airline industry in the second and third quarters of the year tend to be greater than revenues in the first and fourth quarters of the year .", "general economic conditions , fears of terrorism or war , fare initiatives , fluctuations in fuel prices , labor actions , weather , natural disasters , outbreaks of disease and other factors could impact this seasonal pattern .", "therefore , our quarterly results of operations are not necessarily indicative of operating results for the entire year , and historical operating results in a quarterly or annual period are not necessarily indicative of future operating results .", "domestic and global regulatory landscape general airlines are subject to extensive domestic and international regulatory requirements .", "domestically , the dot and the federal aviation administration ( faa ) exercise significant regulatory authority over air carriers .", "the dot , among other things , oversees domestic and international codeshare agreements , international route authorities , competition and consumer protection matters such as advertising , denied boarding compensation and baggage liability .", "the antitrust division of the department of justice ( doj ) , along with the dot in certain instances , have jurisdiction over airline antitrust matters. ."], "table": [["year", "gallons", "average priceper gallon", "aircraft fuelexpense", "percent of totaloperating expenses"], ["2018", "4447", "$ 2.23", "$ 9896", "23.6% ( 23.6 % )"], ["2017", "4352", "1.73", "7510", "19.6% ( 19.6 % )"], ["2016", "4347", "1.42", "6180", "17.6% ( 17.6 % )"]], "table_ori": [["Year", "Gallons", "Average Priceper Gallon", "Aircraft FuelExpense", "Percent of TotalOperating Expenses"], ["2018", "4,447", "$2.23", "$9,896", "23.6%"], ["2017", "4,352", "1.73", "7,510", "19.6%"], ["2016", "4,347", "1.42", "6,180", "17.6%"]]} | divide(7510, 19.6%) |
what was the total aircraft fuel expense from 2016 to 2018 in millions | {"label_key": "AAL_2018", "label_file": "fin_qa", "q_uid": "AAL/2018/page_13.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "23586", "exe_answer": 23586.0} | {"table_1": "year the 2018 of gallons is 4447 ; the 2018 of average priceper gallon is $ 2.23 ; the 2018 of aircraft fuelexpense is $ 9896 ; the 2018 of percent of totaloperating expenses is 23.6% ( 23.6 % ) ;", "table_2": "year the 2017 of gallons is 4352 ; the 2017 of average priceper gallon is 1.73 ; the 2017 of aircraft fuelexpense is 7510 ; the 2017 of percent of totaloperating expenses is 19.6% ( 19.6 % ) ;", "table_3": "year the 2016 of gallons is 4347 ; the 2016 of average priceper gallon is 1.42 ; the 2016 of aircraft fuelexpense is 6180 ; the 2016 of percent of totaloperating expenses is 17.6% ( 17.6 % ) ;"} | {"pre_text": ["the following table shows annual aircraft fuel consumption and costs , including taxes , for our mainline and regional operations for 2018 , 2017 and 2016 ( gallons and aircraft fuel expense in millions ) .", "year gallons average price per gallon aircraft fuel expense percent of total operating expenses ."], "post_text": ["as of december 31 , 2018 , we did not have any fuel hedging contracts outstanding to hedge our fuel consumption .", "as such , and assuming we do not enter into any future transactions to hedge our fuel consumption , we will continue to be fully exposed to fluctuations in fuel prices .", "our current policy is not to enter into transactions to hedge our fuel consumption , although we review that policy from time to time based on market conditions and other factors .", "fuel prices have fluctuated substantially over the past several years .", "we cannot predict the future availability , price volatility or cost of aircraft fuel .", "natural disasters ( including hurricanes or similar events in the u.s .", "southeast and on the gulf coast where a significant portion of domestic refining capacity is located ) , political disruptions or wars involving oil-producing countries , economic sanctions imposed against oil-producing countries or specific industry participants , changes in fuel-related governmental policy , the strength of the u.s .", "dollar against foreign currencies , changes in the cost to transport or store petroleum products , changes in access to petroleum product pipelines and terminals , speculation in the energy futures markets , changes in aircraft fuel production capacity , environmental concerns and other unpredictable events may result in fuel supply shortages , distribution challenges , additional fuel price volatility and cost increases in the future .", "see part i , item 1a .", "risk factors 2013 201cour business is very dependent on the price and availability of aircraft fuel .", "continued periods of high volatility in fuel costs , increased fuel prices or significant disruptions in the supply of aircraft fuel could have a significant negative impact on our operating results and liquidity . 201d seasonality and other factors due to the greater demand for air travel during the summer months , revenues in the airline industry in the second and third quarters of the year tend to be greater than revenues in the first and fourth quarters of the year .", "general economic conditions , fears of terrorism or war , fare initiatives , fluctuations in fuel prices , labor actions , weather , natural disasters , outbreaks of disease and other factors could impact this seasonal pattern .", "therefore , our quarterly results of operations are not necessarily indicative of operating results for the entire year , and historical operating results in a quarterly or annual period are not necessarily indicative of future operating results .", "domestic and global regulatory landscape general airlines are subject to extensive domestic and international regulatory requirements .", "domestically , the dot and the federal aviation administration ( faa ) exercise significant regulatory authority over air carriers .", "the dot , among other things , oversees domestic and international codeshare agreements , international route authorities , competition and consumer protection matters such as advertising , denied boarding compensation and baggage liability .", "the antitrust division of the department of justice ( doj ) , along with the dot in certain instances , have jurisdiction over airline antitrust matters. ."], "table": [["year", "gallons", "average priceper gallon", "aircraft fuelexpense", "percent of totaloperating expenses"], ["2018", "4447", "$ 2.23", "$ 9896", "23.6% ( 23.6 % )"], ["2017", "4352", "1.73", "7510", "19.6% ( 19.6 % )"], ["2016", "4347", "1.42", "6180", "17.6% ( 17.6 % )"]], "table_ori": [["Year", "Gallons", "Average Priceper Gallon", "Aircraft FuelExpense", "Percent of TotalOperating Expenses"], ["2018", "4,447", "$2.23", "$9,896", "23.6%"], ["2017", "4,352", "1.73", "7,510", "19.6%"], ["2016", "4,347", "1.42", "6,180", "17.6%"]]} | add(9896, 7510), add(#0, 6180) |
what percentage of total cash and investments as of dec . 29 2012 was comprised of available-for-sale investments? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_71.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "53%", "exe_answer": 0.53232} | {"table_1": "( in millions ) the available-for-sale investments of dec 282013 is $ 18086 ; the available-for-sale investments of dec 292012 is $ 14001 ;", "table_8": "( in millions ) the total cash and investments of dec 282013 is $ 31561 ; the total cash and investments of dec 292012 is $ 26302 ;"} | {"pre_text": ["the fair value of our grants receivable is determined using a discounted cash flow model , which discounts future cash flows using an appropriate yield curve .", "as of december 28 , 2013 , and december 29 , 2012 , the carrying amount of our grants receivable was classified within other current assets and other long-term assets , as applicable .", "our long-term debt recognized at amortized cost is comprised of our senior notes and our convertible debentures .", "the fair value of our senior notes is determined using active market prices , and it is therefore classified as level 1 .", "the fair value of our convertible long-term debt is determined using discounted cash flow models with observable market inputs , and it takes into consideration variables such as interest rate changes , comparable securities , subordination discount , and credit-rating changes , and it is therefore classified as level 2 .", "the nvidia corporation ( nvidia ) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with nvidia in january 2011 .", "we agreed to make payments to nvidia over six years .", "as of december 28 , 2013 , and december 29 , 2012 , the carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities , as applicable .", "the fair value is determined using a discounted cash flow model , which discounts future cash flows using our incremental borrowing rates .", "note 5 : cash and investments cash and investments at the end of each period were as follows : ( in millions ) dec 28 , dec 29 ."], "post_text": ["in the third quarter of 2013 , we sold our shares in clearwire corporation , which had been accounted for as available-for-sale marketable equity securities , and our interest in clearwire communications , llc ( clearwire llc ) , which had been accounted for as an equity method investment .", "in total , we received proceeds of $ 470 million on these transactions and recognized a gain of $ 439 million , which is included in gains ( losses ) on equity investments , net on the consolidated statements of income .", "proceeds received and gains recognized for each investment are included in the \"available-for-sale investments\" and \"equity method investments\" sections that follow .", "table of contents intel corporation notes to consolidated financial statements ( continued ) ."], "table": [["( in millions )", "dec 282013", "dec 292012"], ["available-for-sale investments", "$ 18086", "$ 14001"], ["cash", "854", "593"], ["equity method investments", "1038", "992"], ["loans receivable", "1072", "979"], ["non-marketable cost method investments", "1270", "1202"], ["reverse repurchase agreements", "800", "2850"], ["trading assets", "8441", "5685"], ["total cash and investments", "$ 31561", "$ 26302"]], "table_ori": [["(In Millions)", "Dec 28,2013", "Dec 29,2012"], ["Available-for-sale investments", "$18,086", "$14,001"], ["Cash", "854", "593"], ["Equity method investments", "1,038", "992"], ["Loans receivable", "1,072", "979"], ["Non-marketable cost method investments", "1,270", "1,202"], ["Reverse repurchase agreements", "800", "2,850"], ["Trading assets", "8,441", "5,685"], ["Total cash and investments", "$31,561", "$26,302"]]} | divide(14001, 26302) |
as part of the proceeds from the clear wire transactions what was the percent of the gain recognized included in the equity investments , net on the consolidated statements of income . | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_71.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "93.4%", "exe_answer": 0.93404} | {"text_9": "note 5 : cash and investments cash and investments at the end of each period were as follows : ( in millions ) dec 28 , dec 29 .", "text_11": "in total , we received proceeds of $ 470 million on these transactions and recognized a gain of $ 439 million , which is included in gains ( losses ) on equity investments , net on the consolidated statements of income ."} | {"pre_text": ["the fair value of our grants receivable is determined using a discounted cash flow model , which discounts future cash flows using an appropriate yield curve .", "as of december 28 , 2013 , and december 29 , 2012 , the carrying amount of our grants receivable was classified within other current assets and other long-term assets , as applicable .", "our long-term debt recognized at amortized cost is comprised of our senior notes and our convertible debentures .", "the fair value of our senior notes is determined using active market prices , and it is therefore classified as level 1 .", "the fair value of our convertible long-term debt is determined using discounted cash flow models with observable market inputs , and it takes into consideration variables such as interest rate changes , comparable securities , subordination discount , and credit-rating changes , and it is therefore classified as level 2 .", "the nvidia corporation ( nvidia ) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with nvidia in january 2011 .", "we agreed to make payments to nvidia over six years .", "as of december 28 , 2013 , and december 29 , 2012 , the carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities , as applicable .", "the fair value is determined using a discounted cash flow model , which discounts future cash flows using our incremental borrowing rates .", "note 5 : cash and investments cash and investments at the end of each period were as follows : ( in millions ) dec 28 , dec 29 ."], "post_text": ["in the third quarter of 2013 , we sold our shares in clearwire corporation , which had been accounted for as available-for-sale marketable equity securities , and our interest in clearwire communications , llc ( clearwire llc ) , which had been accounted for as an equity method investment .", "in total , we received proceeds of $ 470 million on these transactions and recognized a gain of $ 439 million , which is included in gains ( losses ) on equity investments , net on the consolidated statements of income .", "proceeds received and gains recognized for each investment are included in the \"available-for-sale investments\" and \"equity method investments\" sections that follow .", "table of contents intel corporation notes to consolidated financial statements ( continued ) ."], "table": [["( in millions )", "dec 282013", "dec 292012"], ["available-for-sale investments", "$ 18086", "$ 14001"], ["cash", "854", "593"], ["equity method investments", "1038", "992"], ["loans receivable", "1072", "979"], ["non-marketable cost method investments", "1270", "1202"], ["reverse repurchase agreements", "800", "2850"], ["trading assets", "8441", "5685"], ["total cash and investments", "$ 31561", "$ 26302"]], "table_ori": [["(In Millions)", "Dec 28,2013", "Dec 29,2012"], ["Available-for-sale investments", "$18,086", "$14,001"], ["Cash", "854", "593"], ["Equity method investments", "1,038", "992"], ["Loans receivable", "1,072", "979"], ["Non-marketable cost method investments", "1,270", "1,202"], ["Reverse repurchase agreements", "800", "2,850"], ["Trading assets", "8,441", "5,685"], ["Total cash and investments", "$31,561", "$26,302"]]} | divide(439, 470) |
what was the percent of the pension plans and other post retirement benefit plans included in the total other long-term liabilities as of december 28 , 2013 | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_50.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "4.1%", "exe_answer": 0.04144} | {"table_5": "( in millions ) the other long-term liabilities4 5 of payments due by period total is 1496 ; the other long-term liabilities4 5 of payments due by period less than1 year is 569 ; the other long-term liabilities4 5 of payments due by period 1 20133 years is 663 ; the other long-term liabilities4 5 of payments due by period 3 20135 years is 144 ; the other long-term liabilities4 5 of payments due by period more than5 years is 120 ;", "text_13": "and non-u.s .", "text_14": "pension plans and other postretirement benefit plans of $ 62 million to be made during 2014 are also included ; however , funding projections beyond 2014 are not practicable to estimate ."} | {"pre_text": ["contractual obligations the following table summarizes our significant contractual obligations as of december 28 , 2013: ."], "post_text": ["capital purchase obligations1 5503 5375 125 2014 3 other purchase obligations and commitments2 1859 772 744 307 36 long-term debt obligations3 22372 429 2360 3761 15822 other long-term liabilities4 , 5 1496 569 663 144 120 total6 $ 32100 $ 7353 $ 4190 $ 4378 $ 16179 1 capital purchase obligations represent commitments for the construction or purchase of property , plant and equipment .", "they were not recorded as liabilities on our consolidated balance sheets as of december 28 , 2013 , as we had not yet received the related goods or taken title to the property .", "2 other purchase obligations and commitments include payments due under various types of licenses and agreements to purchase goods or services , as well as payments due under non-contingent funding obligations .", "funding obligations include agreements to fund various projects with other companies .", "3 amounts represent principal and interest cash payments over the life of the debt obligations , including anticipated interest payments that are not recorded on our consolidated balance sheets .", "any future settlement of convertible debt would impact our cash payments .", "4 we are unable to reliably estimate the timing of future payments related to uncertain tax positions ; therefore , $ 188 million of long-term income taxes payable has been excluded from the preceding table .", "however , long- term income taxes payable , recorded on our consolidated balance sheets , included these uncertain tax positions , reduced by the associated federal deduction for state taxes and u.s .", "tax credits arising from non- u.s .", "income taxes .", "5 amounts represent future cash payments to satisfy other long-term liabilities recorded on our consolidated balance sheets , including the short-term portion of these long-term liabilities .", "expected required contributions to our u.s .", "and non-u.s .", "pension plans and other postretirement benefit plans of $ 62 million to be made during 2014 are also included ; however , funding projections beyond 2014 are not practicable to estimate .", "6 total excludes contractual obligations already recorded on our consolidated balance sheets as current liabilities except for the short-term portions of long-term debt obligations and other long-term liabilities .", "contractual obligations for purchases of goods or services , included in other purchase obligations and commitments in the preceding table , include agreements that are enforceable and legally binding on intel and that specify all significant terms , including fixed or minimum quantities to be purchased ; fixed , minimum , or variable price provisions ; and the approximate timing of the transaction .", "for obligations with cancellation provisions , the amounts included in the preceding table were limited to the non-cancelable portion of the agreement terms or the minimum cancellation fee .", "we have entered into certain agreements for the purchase of raw materials that specify minimum prices and quantities based on a percentage of the total available market or based on a percentage of our future purchasing requirements .", "due to the uncertainty of the future market and our future purchasing requirements , as well as the non-binding nature of these agreements , obligations under these agreements are not included in the preceding table .", "our purchase orders for other products are based on our current manufacturing needs and are fulfilled by our vendors within short time horizons .", "in addition , some of our purchase orders represent authorizations to purchase rather than binding agreements .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "payments due by period total", "payments due by period less than1 year", "payments due by period 1 20133 years", "payments due by period 3 20135 years", "payments due by period more than5 years"], ["operating lease obligations", "$ 870", "$ 208", "$ 298", "$ 166", "$ 198"], ["capital purchase obligations1", "5503", "5375", "125", "2014", "3"], ["other purchase obligations and commitments2", "1859", "772", "744", "307", "36"], ["long-term debt obligations3", "22372", "429", "2360", "3761", "15822"], ["other long-term liabilities4 5", "1496", "569", "663", "144", "120"], ["total6", "$ 32100", "$ 7353", "$ 4190", "$ 4378", "$ 16179"]], "table_ori": [["", "Payments Due by Period"], ["(In Millions)", "Total", "Less Than1 Year", "1–3 Years", "3–5 Years", "More Than5 Years"], ["Operating lease obligations", "$870", "$208", "$298", "$166", "$198"], ["Capital purchase obligations<sup>1</sup>", "5,503", "5,375", "125", "—", "3"], ["Other purchase obligations and commitments<sup>2</sup>", "1,859", "772", "744", "307", "36"], ["Long-term debt obligations<sup>3</sup>", "22,372", "429", "2,360", "3,761", "15,822"], ["Other long-term liabilities<sup>4, 5</sup>", "1,496", "569", "663", "144", "120"], ["Total<sup>6</sup>", "$32,100", "$7,353", "$4,190", "$4,378", "$16,179"]]} | divide(62, 1496) |
what was the percentage change in net cash provided by operating activities between 2011 and 2012? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_47.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "-10%", "exe_answer": -0.09917} | {"table_1": "( in millions ) the net cash provided by operating activities of 2013 is $ 20776 ; the net cash provided by operating activities of 2012 is $ 18884 ; the net cash provided by operating activities of 2011 is $ 20963 ;"} | {"pre_text": ["in summary , our cash flows for each period were as follows: ."], "post_text": ["operating activities cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities .", "for 2013 compared to 2012 , the $ 1.9 billion increase in cash provided by operating activities was due to changes in working capital , partially offset by lower net income in 2013 .", "income taxes paid , net of refunds , in 2013 compared to 2012 were $ 1.1 billion lower due to lower income before taxes in 2013 and 2012 income tax overpayments .", "changes in assets and liabilities as of december 28 , 2013 , compared to december 29 , 2012 , included lower income taxes payable and receivable resulting from a reduction in taxes due in 2013 , and lower inventories due to the sell-through of older-generation products , partially offset by the ramp of 4th generation intel core processor family products .", "for 2013 , our three largest customers accounted for 44% ( 44 % ) of our net revenue ( 43% ( 43 % ) in 2012 and 2011 ) , with hewlett- packard company accounting for 17% ( 17 % ) of our net revenue ( 18% ( 18 % ) in 2012 and 19% ( 19 % ) in 2011 ) , dell accounting for 15% ( 15 % ) of our net revenue ( 14% ( 14 % ) in 2012 and 15% ( 15 % ) in 2011 ) , and lenovo accounting for 12% ( 12 % ) of our net revenue ( 11% ( 11 % ) in 2012 and 9% ( 9 % ) in 2011 ) .", "these three customers accounted for 34% ( 34 % ) of our accounts receivable as of december 28 , 2013 ( 33% ( 33 % ) as of december 29 , 2012 ) .", "for 2012 compared to 2011 , the $ 2.1 billion decrease in cash provided by operating activities was due to lower net income and changes in our working capital , partially offset by adjustments for non-cash items .", "the adjustments for noncash items were higher due primarily to higher depreciation in 2012 compared to 2011 , partially offset by increases in non-acquisition-related deferred tax liabilities as of december 31 , 2011 .", "investing activities investing cash flows consist primarily of capital expenditures ; investment purchases , sales , maturities , and disposals ; as well as cash used for acquisitions .", "the increase in cash used for investing activities in 2013 compared to 2012 was primarily due to an increase in purchases of available-for-sale investments and a decrease in maturities and sales of trading assets , partially offset by an increase in maturities and sales of available-for-sale investments and a decrease in purchases of licensed technology and patents .", "our capital expenditures were $ 10.7 billion in 2013 ( $ 11.0 billion in 2012 and $ 10.8 billion in 2011 ) .", "cash used for investing activities increased in 2012 compared to 2011 primarily due to net purchases of available- for-sale investments and trading assets in 2012 , as compared to net maturities and sales of available-for-sale investments and trading assets in 2011 , partially offset by a decrease in cash paid for acquisitions .", "net purchases of available-for-sale investments in 2012 included our purchase of $ 3.2 billion of equity securities in asml in q3 2012 .", "financing activities financing cash flows consist primarily of repurchases of common stock , payment of dividends to stockholders , issuance and repayment of long-term debt , and proceeds from the sale of shares through employee equity incentive plans .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "2013", "2012", "2011"], ["net cash provided by operating activities", "$ 20776", "$ 18884", "$ 20963"], ["net cash used for investing activities", "-18073 ( 18073 )", "-14060 ( 14060 )", "-10301 ( 10301 )"], ["net cash used for financing activities", "-5498 ( 5498 )", "-1408 ( 1408 )", "-11100 ( 11100 )"], ["effect of exchange rate fluctuations on cash and cash equivalents", "-9 ( 9 )", "-3 ( 3 )", "5"], ["net increase ( decrease ) in cash and cash equivalents", "$ -2804 ( 2804 )", "$ 3413", "$ -433 ( 433 )"]], "table_ori": [["(In Millions)", "2013", "2012", "2011"], ["Net cash provided by operating activities", "$20,776", "$18,884", "$20,963"], ["Net cash used for investing activities", "(18,073)", "(14,060)", "(10,301)"], ["Net cash used for financing activities", "(5,498)", "(1,408)", "(11,100)"], ["Effect of exchange rate fluctuations on cash and cash equivalents", "(9)", "(3)", "5"], ["Net increase (decrease) in cash and cash equivalents", "$(2,804)", "$3,413", "$(433)"]]} | subtract(18884, 20963), divide(#0, 20963) |
in 2013 what was the approximate percentage increase in net cash provided by operating activities | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_47.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "10%", "exe_answer": 0.00101} | {"table_1": "( in millions ) the net cash provided by operating activities of 2013 is $ 20776 ; the net cash provided by operating activities of 2012 is $ 18884 ; the net cash provided by operating activities of 2011 is $ 20963 ;", "text_2": "for 2013 compared to 2012 , the $ 1.9 billion increase in cash provided by operating activities was due to changes in working capital , partially offset by lower net income in 2013 .", "text_5": "for 2013 , our three largest customers accounted for 44% ( 44 % ) of our net revenue ( 43% ( 43 % ) in 2012 and 2011 ) , with hewlett- packard company accounting for 17% ( 17 % ) of our net revenue ( 18% ( 18 % ) in 2012 and 19% ( 19 % ) in 2011 ) , dell accounting for 15% ( 15 % ) of our net revenue ( 14% ( 14 % ) in 2012 and 15% ( 15 % ) in 2011 ) , and lenovo accounting for 12% ( 12 % ) of our net revenue ( 11% ( 11 % ) in 2012 and 9% ( 9 % ) in 2011 ) ."} | {"pre_text": ["in summary , our cash flows for each period were as follows: ."], "post_text": ["operating activities cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities .", "for 2013 compared to 2012 , the $ 1.9 billion increase in cash provided by operating activities was due to changes in working capital , partially offset by lower net income in 2013 .", "income taxes paid , net of refunds , in 2013 compared to 2012 were $ 1.1 billion lower due to lower income before taxes in 2013 and 2012 income tax overpayments .", "changes in assets and liabilities as of december 28 , 2013 , compared to december 29 , 2012 , included lower income taxes payable and receivable resulting from a reduction in taxes due in 2013 , and lower inventories due to the sell-through of older-generation products , partially offset by the ramp of 4th generation intel core processor family products .", "for 2013 , our three largest customers accounted for 44% ( 44 % ) of our net revenue ( 43% ( 43 % ) in 2012 and 2011 ) , with hewlett- packard company accounting for 17% ( 17 % ) of our net revenue ( 18% ( 18 % ) in 2012 and 19% ( 19 % ) in 2011 ) , dell accounting for 15% ( 15 % ) of our net revenue ( 14% ( 14 % ) in 2012 and 15% ( 15 % ) in 2011 ) , and lenovo accounting for 12% ( 12 % ) of our net revenue ( 11% ( 11 % ) in 2012 and 9% ( 9 % ) in 2011 ) .", "these three customers accounted for 34% ( 34 % ) of our accounts receivable as of december 28 , 2013 ( 33% ( 33 % ) as of december 29 , 2012 ) .", "for 2012 compared to 2011 , the $ 2.1 billion decrease in cash provided by operating activities was due to lower net income and changes in our working capital , partially offset by adjustments for non-cash items .", "the adjustments for noncash items were higher due primarily to higher depreciation in 2012 compared to 2011 , partially offset by increases in non-acquisition-related deferred tax liabilities as of december 31 , 2011 .", "investing activities investing cash flows consist primarily of capital expenditures ; investment purchases , sales , maturities , and disposals ; as well as cash used for acquisitions .", "the increase in cash used for investing activities in 2013 compared to 2012 was primarily due to an increase in purchases of available-for-sale investments and a decrease in maturities and sales of trading assets , partially offset by an increase in maturities and sales of available-for-sale investments and a decrease in purchases of licensed technology and patents .", "our capital expenditures were $ 10.7 billion in 2013 ( $ 11.0 billion in 2012 and $ 10.8 billion in 2011 ) .", "cash used for investing activities increased in 2012 compared to 2011 primarily due to net purchases of available- for-sale investments and trading assets in 2012 , as compared to net maturities and sales of available-for-sale investments and trading assets in 2011 , partially offset by a decrease in cash paid for acquisitions .", "net purchases of available-for-sale investments in 2012 included our purchase of $ 3.2 billion of equity securities in asml in q3 2012 .", "financing activities financing cash flows consist primarily of repurchases of common stock , payment of dividends to stockholders , issuance and repayment of long-term debt , and proceeds from the sale of shares through employee equity incentive plans .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "2013", "2012", "2011"], ["net cash provided by operating activities", "$ 20776", "$ 18884", "$ 20963"], ["net cash used for investing activities", "-18073 ( 18073 )", "-14060 ( 14060 )", "-10301 ( 10301 )"], ["net cash used for financing activities", "-5498 ( 5498 )", "-1408 ( 1408 )", "-11100 ( 11100 )"], ["effect of exchange rate fluctuations on cash and cash equivalents", "-9 ( 9 )", "-3 ( 3 )", "5"], ["net increase ( decrease ) in cash and cash equivalents", "$ -2804 ( 2804 )", "$ 3413", "$ -433 ( 433 )"]], "table_ori": [["(In Millions)", "2013", "2012", "2011"], ["Net cash provided by operating activities", "$20,776", "$18,884", "$20,963"], ["Net cash used for investing activities", "(18,073)", "(14,060)", "(10,301)"], ["Net cash used for financing activities", "(5,498)", "(1,408)", "(11,100)"], ["Effect of exchange rate fluctuations on cash and cash equivalents", "(9)", "(3)", "5"], ["Net increase (decrease) in cash and cash equivalents", "$(2,804)", "$3,413", "$(433)"]]} | divide(19, 18884) |
what was the percentage change in net cash provided by operating activities between 2012 and 2013? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_47.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "10%", "exe_answer": 0.10019} | {"table_1": "( in millions ) the net cash provided by operating activities of 2013 is $ 20776 ; the net cash provided by operating activities of 2012 is $ 18884 ; the net cash provided by operating activities of 2011 is $ 20963 ;"} | {"pre_text": ["in summary , our cash flows for each period were as follows: ."], "post_text": ["operating activities cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities .", "for 2013 compared to 2012 , the $ 1.9 billion increase in cash provided by operating activities was due to changes in working capital , partially offset by lower net income in 2013 .", "income taxes paid , net of refunds , in 2013 compared to 2012 were $ 1.1 billion lower due to lower income before taxes in 2013 and 2012 income tax overpayments .", "changes in assets and liabilities as of december 28 , 2013 , compared to december 29 , 2012 , included lower income taxes payable and receivable resulting from a reduction in taxes due in 2013 , and lower inventories due to the sell-through of older-generation products , partially offset by the ramp of 4th generation intel core processor family products .", "for 2013 , our three largest customers accounted for 44% ( 44 % ) of our net revenue ( 43% ( 43 % ) in 2012 and 2011 ) , with hewlett- packard company accounting for 17% ( 17 % ) of our net revenue ( 18% ( 18 % ) in 2012 and 19% ( 19 % ) in 2011 ) , dell accounting for 15% ( 15 % ) of our net revenue ( 14% ( 14 % ) in 2012 and 15% ( 15 % ) in 2011 ) , and lenovo accounting for 12% ( 12 % ) of our net revenue ( 11% ( 11 % ) in 2012 and 9% ( 9 % ) in 2011 ) .", "these three customers accounted for 34% ( 34 % ) of our accounts receivable as of december 28 , 2013 ( 33% ( 33 % ) as of december 29 , 2012 ) .", "for 2012 compared to 2011 , the $ 2.1 billion decrease in cash provided by operating activities was due to lower net income and changes in our working capital , partially offset by adjustments for non-cash items .", "the adjustments for noncash items were higher due primarily to higher depreciation in 2012 compared to 2011 , partially offset by increases in non-acquisition-related deferred tax liabilities as of december 31 , 2011 .", "investing activities investing cash flows consist primarily of capital expenditures ; investment purchases , sales , maturities , and disposals ; as well as cash used for acquisitions .", "the increase in cash used for investing activities in 2013 compared to 2012 was primarily due to an increase in purchases of available-for-sale investments and a decrease in maturities and sales of trading assets , partially offset by an increase in maturities and sales of available-for-sale investments and a decrease in purchases of licensed technology and patents .", "our capital expenditures were $ 10.7 billion in 2013 ( $ 11.0 billion in 2012 and $ 10.8 billion in 2011 ) .", "cash used for investing activities increased in 2012 compared to 2011 primarily due to net purchases of available- for-sale investments and trading assets in 2012 , as compared to net maturities and sales of available-for-sale investments and trading assets in 2011 , partially offset by a decrease in cash paid for acquisitions .", "net purchases of available-for-sale investments in 2012 included our purchase of $ 3.2 billion of equity securities in asml in q3 2012 .", "financing activities financing cash flows consist primarily of repurchases of common stock , payment of dividends to stockholders , issuance and repayment of long-term debt , and proceeds from the sale of shares through employee equity incentive plans .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "2013", "2012", "2011"], ["net cash provided by operating activities", "$ 20776", "$ 18884", "$ 20963"], ["net cash used for investing activities", "-18073 ( 18073 )", "-14060 ( 14060 )", "-10301 ( 10301 )"], ["net cash used for financing activities", "-5498 ( 5498 )", "-1408 ( 1408 )", "-11100 ( 11100 )"], ["effect of exchange rate fluctuations on cash and cash equivalents", "-9 ( 9 )", "-3 ( 3 )", "5"], ["net increase ( decrease ) in cash and cash equivalents", "$ -2804 ( 2804 )", "$ 3413", "$ -433 ( 433 )"]], "table_ori": [["(In Millions)", "2013", "2012", "2011"], ["Net cash provided by operating activities", "$20,776", "$18,884", "$20,963"], ["Net cash used for investing activities", "(18,073)", "(14,060)", "(10,301)"], ["Net cash used for financing activities", "(5,498)", "(1,408)", "(11,100)"], ["Effect of exchange rate fluctuations on cash and cash equivalents", "(9)", "(3)", "5"], ["Net increase (decrease) in cash and cash equivalents", "$(2,804)", "$3,413", "$(433)"]]} | subtract(20776, 18884), divide(#0, 18884) |
in 2013 what was the operating margin | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_40.pdf-3", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "35.8%", "exe_answer": 0.35797} | {"table_1": "( in millions ) the net revenue of 2013 is $ 33039 ; the net revenue of 2012 is $ 34504 ; the net revenue of 2011 is $ 35624 ;", "table_2": "( in millions ) the operating income of 2013 is $ 11827 ; the operating income of 2012 is $ 13106 ; the operating income of 2011 is $ 14840 ;"} | {"pre_text": ["our overall gross margin percentage decreased to 59.8% ( 59.8 % ) in 2013 from 62.1% ( 62.1 % ) in 2012 .", "the decrease in the gross margin percentage was primarily due to the gross margin percentage decrease in pccg .", "we derived most of our overall gross margin dollars in 2013 and 2012 from the sale of platforms in the pccg and dcg operating segments .", "our net revenue for 2012 , which included 52 weeks , decreased by $ 658 million , or 1% ( 1 % ) , compared to 2011 , which included 53 weeks .", "the pccg and dcg platform unit sales decreased 1% ( 1 % ) while average selling prices were unchanged .", "additionally , lower netbook platform unit sales and multi-comm average selling prices , primarily discrete modems , contributed to the decrease .", "these decreases were partially offset by our mcafee operating segment , which we acquired in the q1 2011 .", "mcafee contributed $ 469 million of additional revenue in 2012 compared to 2011 .", "our overall gross margin dollars for 2012 decreased by $ 606 million , or 2% ( 2 % ) , compared to 2011 .", "the decrease was due in large part to $ 494 million of excess capacity charges , as well as lower revenue from the pccg and dcg platform .", "to a lesser extent , approximately $ 390 million of higher unit costs on the pccg and dcg platform as well as lower netbook and multi-comm revenue contributed to the decrease .", "the decrease was partially offset by $ 643 million of lower factory start-up costs as we transition from our 22nm process technology to r&d of our next- generation 14nm process technology , as well as $ 422 million of charges recorded in 2011 to repair and replace materials and systems impacted by a design issue related to our intel ae 6 series express chipset family .", "the decrease was also partially offset by the two additional months of results from our acquisition of mcafee , which occurred on february 28 , 2011 , contributing approximately $ 334 million of additional gross margin dollars in 2012 compared to 2011 .", "the amortization of acquisition-related intangibles resulted in a $ 557 million reduction to our overall gross margin dollars in 2012 , compared to $ 482 million in 2011 , primarily due to acquisitions completed in q1 2011 .", "our overall gross margin percentage in 2012 was flat from 2011 as higher excess capacity charges and higher unit costs on the pccg and dcg platform were offset by lower factory start-up costs and no impact in 2012 for a design issue related to our intel 6 series express chipset family .", "we derived a substantial majority of our overall gross margin dollars in 2012 and 2011 from the sale of platforms in the pccg and dcg operating segments .", "pc client group the revenue and operating income for the pccg operating segment for each period were as follows: ."], "post_text": ["net revenue for the pccg operating segment decreased by $ 1.5 billion , or 4% ( 4 % ) , in 2013 compared to 2012 .", "pccg platform unit sales were down 3% ( 3 % ) primarily on softness in traditional pc demand during the first nine months of the year .", "the decrease in revenue was driven by lower notebook and desktop platform unit sales which were down 4% ( 4 % ) and 2% ( 2 % ) , respectively .", "pccg platform average selling prices were flat , with 6% ( 6 % ) higher desktop platform average selling prices offset by 4% ( 4 % ) lower notebook platform average selling prices .", "operating income decreased by $ 1.3 billion , or 10% ( 10 % ) , in 2013 compared to 2012 , which was driven by $ 1.5 billion of lower gross margin , partially offset by $ 200 million of lower operating expenses .", "the decrease in gross margin was driven by $ 1.5 billion of higher factory start-up costs primarily on our next-generation 14nm process technology as well as lower pccg platform revenue .", "these decreases were partially offset by approximately $ 520 million of lower pccg platform unit costs , $ 260 million of lower excess capacity charges , and higher sell-through of previously non- qualified units .", "net revenue for the pccg operating segment decreased by $ 1.1 billion , or 3% ( 3 % ) , in 2012 compared to 2011 .", "pccg revenue was negatively impacted by the growth of tablets as these devices compete with pcs for consumer sales .", "platform average selling prices and unit sales decreased 2% ( 2 % ) and 1% ( 1 % ) , respectively .", "the decrease was driven by 6% ( 6 % ) lower notebook platform average selling prices and 5% ( 5 % ) lower desktop platform unit sales .", "these decreases were partially offset by a 4% ( 4 % ) increase in desktop platform average selling prices and a 2% ( 2 % ) increase in notebook platform unit sales .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "2013", "2012", "2011"], ["net revenue", "$ 33039", "$ 34504", "$ 35624"], ["operating income", "$ 11827", "$ 13106", "$ 14840"]], "table_ori": [["(In Millions)", "2013", "2012", "2011"], ["Net revenue", "$33,039", "$34,504", "$35,624"], ["Operating income", "$11,827", "$13,106", "$14,840"]]} | divide(11827, 33039) |
what was the operating margin for the pc client group in 2013? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_40.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "36%", "exe_answer": 0.35797} | {"table_1": "( in millions ) the net revenue of 2013 is $ 33039 ; the net revenue of 2012 is $ 34504 ; the net revenue of 2011 is $ 35624 ;", "table_2": "( in millions ) the operating income of 2013 is $ 11827 ; the operating income of 2012 is $ 13106 ; the operating income of 2011 is $ 14840 ;"} | {"pre_text": ["our overall gross margin percentage decreased to 59.8% ( 59.8 % ) in 2013 from 62.1% ( 62.1 % ) in 2012 .", "the decrease in the gross margin percentage was primarily due to the gross margin percentage decrease in pccg .", "we derived most of our overall gross margin dollars in 2013 and 2012 from the sale of platforms in the pccg and dcg operating segments .", "our net revenue for 2012 , which included 52 weeks , decreased by $ 658 million , or 1% ( 1 % ) , compared to 2011 , which included 53 weeks .", "the pccg and dcg platform unit sales decreased 1% ( 1 % ) while average selling prices were unchanged .", "additionally , lower netbook platform unit sales and multi-comm average selling prices , primarily discrete modems , contributed to the decrease .", "these decreases were partially offset by our mcafee operating segment , which we acquired in the q1 2011 .", "mcafee contributed $ 469 million of additional revenue in 2012 compared to 2011 .", "our overall gross margin dollars for 2012 decreased by $ 606 million , or 2% ( 2 % ) , compared to 2011 .", "the decrease was due in large part to $ 494 million of excess capacity charges , as well as lower revenue from the pccg and dcg platform .", "to a lesser extent , approximately $ 390 million of higher unit costs on the pccg and dcg platform as well as lower netbook and multi-comm revenue contributed to the decrease .", "the decrease was partially offset by $ 643 million of lower factory start-up costs as we transition from our 22nm process technology to r&d of our next- generation 14nm process technology , as well as $ 422 million of charges recorded in 2011 to repair and replace materials and systems impacted by a design issue related to our intel ae 6 series express chipset family .", "the decrease was also partially offset by the two additional months of results from our acquisition of mcafee , which occurred on february 28 , 2011 , contributing approximately $ 334 million of additional gross margin dollars in 2012 compared to 2011 .", "the amortization of acquisition-related intangibles resulted in a $ 557 million reduction to our overall gross margin dollars in 2012 , compared to $ 482 million in 2011 , primarily due to acquisitions completed in q1 2011 .", "our overall gross margin percentage in 2012 was flat from 2011 as higher excess capacity charges and higher unit costs on the pccg and dcg platform were offset by lower factory start-up costs and no impact in 2012 for a design issue related to our intel 6 series express chipset family .", "we derived a substantial majority of our overall gross margin dollars in 2012 and 2011 from the sale of platforms in the pccg and dcg operating segments .", "pc client group the revenue and operating income for the pccg operating segment for each period were as follows: ."], "post_text": ["net revenue for the pccg operating segment decreased by $ 1.5 billion , or 4% ( 4 % ) , in 2013 compared to 2012 .", "pccg platform unit sales were down 3% ( 3 % ) primarily on softness in traditional pc demand during the first nine months of the year .", "the decrease in revenue was driven by lower notebook and desktop platform unit sales which were down 4% ( 4 % ) and 2% ( 2 % ) , respectively .", "pccg platform average selling prices were flat , with 6% ( 6 % ) higher desktop platform average selling prices offset by 4% ( 4 % ) lower notebook platform average selling prices .", "operating income decreased by $ 1.3 billion , or 10% ( 10 % ) , in 2013 compared to 2012 , which was driven by $ 1.5 billion of lower gross margin , partially offset by $ 200 million of lower operating expenses .", "the decrease in gross margin was driven by $ 1.5 billion of higher factory start-up costs primarily on our next-generation 14nm process technology as well as lower pccg platform revenue .", "these decreases were partially offset by approximately $ 520 million of lower pccg platform unit costs , $ 260 million of lower excess capacity charges , and higher sell-through of previously non- qualified units .", "net revenue for the pccg operating segment decreased by $ 1.1 billion , or 3% ( 3 % ) , in 2012 compared to 2011 .", "pccg revenue was negatively impacted by the growth of tablets as these devices compete with pcs for consumer sales .", "platform average selling prices and unit sales decreased 2% ( 2 % ) and 1% ( 1 % ) , respectively .", "the decrease was driven by 6% ( 6 % ) lower notebook platform average selling prices and 5% ( 5 % ) lower desktop platform unit sales .", "these decreases were partially offset by a 4% ( 4 % ) increase in desktop platform average selling prices and a 2% ( 2 % ) increase in notebook platform unit sales .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "2013", "2012", "2011"], ["net revenue", "$ 33039", "$ 34504", "$ 35624"], ["operating income", "$ 11827", "$ 13106", "$ 14840"]], "table_ori": [["(In Millions)", "2013", "2012", "2011"], ["Net revenue", "$33,039", "$34,504", "$35,624"], ["Operating income", "$11,827", "$13,106", "$14,840"]]} | divide(11827, 33039) |
what is the net cash flow from short-term debt in 2013? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_86.pdf-2", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "-31", "exe_answer": -31.0} | {"text_5": "note 16 : borrowings short-term debt as of december 28 , 2013 , short-term debt consisted of drafts payable of $ 257 million and notes payable of $ 24 million ( drafts payable of $ 264 million and notes payable of $ 48 million as of december 29 , 2012 ) ."} | {"pre_text": ["note 15 : chipset design issue in january 2011 , as part of our ongoing quality assurance procedures , we identified a design issue with the intel ae 6 series express chipset family .", "the issue affected chipsets sold in the fourth quarter of 2010 and january 2011 .", "we subsequently implemented a silicon fix and began shipping the updated version of the affected chipset in february 2011 .", "the total cost in 2011 to repair and replace affected materials and systems , located with customers and in the market , was $ 422 million .", "we do not expect to have any significant future adjustments related to this issue .", "note 16 : borrowings short-term debt as of december 28 , 2013 , short-term debt consisted of drafts payable of $ 257 million and notes payable of $ 24 million ( drafts payable of $ 264 million and notes payable of $ 48 million as of december 29 , 2012 ) .", "we have an ongoing authorization from our board of directors to borrow up to $ 3.0 billion , including through the issuance of commercial paper .", "maximum borrowings under our commercial paper program during 2013 were $ 300 million ( $ 500 million during 2012 ) .", "our commercial paper was rated a-1+ by standard & poor 2019s and p-1 by moody 2019s as of december 28 , 2013 .", "long-term debt our long-term debt at the end of each period was as follows : ( in millions ) dec 28 , dec 29 ."], "post_text": ["senior notes in the fourth quarter of 2012 , we issued $ 6.2 billion aggregate principal amount of senior unsecured notes for general corporate purposes and to repurchase shares of our common stock pursuant to our authorized common stock repurchase program .", "in the third quarter of 2011 , we issued $ 5.0 billion aggregate principal amount of senior unsecured notes , primarily to repurchase shares of our common stock pursuant to our authorized common stock repurchase program , and for general corporate purposes .", "our senior notes pay a fixed rate of interest semiannually .", "we may redeem our senior notes , in whole or in part , at any time at our option at specified redemption prices .", "the senior notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and will effectively rank junior to all liabilities of our subsidiaries .", "table of contents intel corporation notes to consolidated financial statements ( continued ) ."], "table": [["( in millions )", "dec 282013", "dec 292012"], ["2012 senior notes due 2017 at 1.35% ( 1.35 % )", "$ 2997", "$ 2997"], ["2012 senior notes due 2022 at 2.70% ( 2.70 % )", "1494", "1494"], ["2012 senior notes due 2032 at 4.00% ( 4.00 % )", "744", "743"], ["2012 senior notes due 2042 at 4.25% ( 4.25 % )", "924", "924"], ["2011 senior notes due 2016 at 1.95% ( 1.95 % )", "1499", "1498"], ["2011 senior notes due 2021 at 3.30% ( 3.30 % )", "1996", "1996"], ["2011 senior notes due 2041 at 4.80% ( 4.80 % )", "1490", "1489"], ["2009 junior subordinated convertible debentures due 2039 at 3.25% ( 3.25 % )", "1075", "1063"], ["2005 junior subordinated convertible debentures due 2035 at 2.95% ( 2.95 % )", "946", "932"], ["total long-term debt", "$ 13165", "$ 13136"]], "table_ori": [["(In Millions)", "Dec 28,2013", "Dec 29,2012"], ["2012 Senior notes due 2017 at 1.35%", "$2,997", "$2,997"], ["2012 Senior notes due 2022 at 2.70%", "1,494", "1,494"], ["2012 Senior notes due 2032 at 4.00%", "744", "743"], ["2012 Senior notes due 2042 at 4.25%", "924", "924"], ["2011 Senior notes due 2016 at 1.95%", "1,499", "1,498"], ["2011 Senior notes due 2021 at 3.30%", "1,996", "1,996"], ["2011 Senior notes due 2041 at 4.80%", "1,490", "1,489"], ["2009 Junior subordinated convertible debentures due 2039 at 3.25%", "1,075", "1,063"], ["2005 Junior subordinated convertible debentures due 2035 at 2.95%", "946", "932"], ["Total long-term debt", "$13,165", "$13,136"]]} | add(257, 24), add(264, 48), subtract(#0, #1) |
what percentage of total contractual obligations as of december 28 , 2013 is made up of long-term debt obligations? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_50.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "70%", "exe_answer": 0.69695} | {"table_4": "( in millions ) the long-term debt obligations3 of payments due by period total is 22372 ; the long-term debt obligations3 of payments due by period less than1 year is 429 ; the long-term debt obligations3 of payments due by period 1 20133 years is 2360 ; the long-term debt obligations3 of payments due by period 3 20135 years is 3761 ; the long-term debt obligations3 of payments due by period more than5 years is 15822 ;", "table_6": "( in millions ) the total6 of payments due by period total is $ 32100 ; the total6 of payments due by period less than1 year is $ 7353 ; the total6 of payments due by period 1 20133 years is $ 4190 ; the total6 of payments due by period 3 20135 years is $ 4378 ; the total6 of payments due by period more than5 years is $ 16179 ;"} | {"pre_text": ["contractual obligations the following table summarizes our significant contractual obligations as of december 28 , 2013: ."], "post_text": ["capital purchase obligations1 5503 5375 125 2014 3 other purchase obligations and commitments2 1859 772 744 307 36 long-term debt obligations3 22372 429 2360 3761 15822 other long-term liabilities4 , 5 1496 569 663 144 120 total6 $ 32100 $ 7353 $ 4190 $ 4378 $ 16179 1 capital purchase obligations represent commitments for the construction or purchase of property , plant and equipment .", "they were not recorded as liabilities on our consolidated balance sheets as of december 28 , 2013 , as we had not yet received the related goods or taken title to the property .", "2 other purchase obligations and commitments include payments due under various types of licenses and agreements to purchase goods or services , as well as payments due under non-contingent funding obligations .", "funding obligations include agreements to fund various projects with other companies .", "3 amounts represent principal and interest cash payments over the life of the debt obligations , including anticipated interest payments that are not recorded on our consolidated balance sheets .", "any future settlement of convertible debt would impact our cash payments .", "4 we are unable to reliably estimate the timing of future payments related to uncertain tax positions ; therefore , $ 188 million of long-term income taxes payable has been excluded from the preceding table .", "however , long- term income taxes payable , recorded on our consolidated balance sheets , included these uncertain tax positions , reduced by the associated federal deduction for state taxes and u.s .", "tax credits arising from non- u.s .", "income taxes .", "5 amounts represent future cash payments to satisfy other long-term liabilities recorded on our consolidated balance sheets , including the short-term portion of these long-term liabilities .", "expected required contributions to our u.s .", "and non-u.s .", "pension plans and other postretirement benefit plans of $ 62 million to be made during 2014 are also included ; however , funding projections beyond 2014 are not practicable to estimate .", "6 total excludes contractual obligations already recorded on our consolidated balance sheets as current liabilities except for the short-term portions of long-term debt obligations and other long-term liabilities .", "contractual obligations for purchases of goods or services , included in other purchase obligations and commitments in the preceding table , include agreements that are enforceable and legally binding on intel and that specify all significant terms , including fixed or minimum quantities to be purchased ; fixed , minimum , or variable price provisions ; and the approximate timing of the transaction .", "for obligations with cancellation provisions , the amounts included in the preceding table were limited to the non-cancelable portion of the agreement terms or the minimum cancellation fee .", "we have entered into certain agreements for the purchase of raw materials that specify minimum prices and quantities based on a percentage of the total available market or based on a percentage of our future purchasing requirements .", "due to the uncertainty of the future market and our future purchasing requirements , as well as the non-binding nature of these agreements , obligations under these agreements are not included in the preceding table .", "our purchase orders for other products are based on our current manufacturing needs and are fulfilled by our vendors within short time horizons .", "in addition , some of our purchase orders represent authorizations to purchase rather than binding agreements .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "payments due by period total", "payments due by period less than1 year", "payments due by period 1 20133 years", "payments due by period 3 20135 years", "payments due by period more than5 years"], ["operating lease obligations", "$ 870", "$ 208", "$ 298", "$ 166", "$ 198"], ["capital purchase obligations1", "5503", "5375", "125", "2014", "3"], ["other purchase obligations and commitments2", "1859", "772", "744", "307", "36"], ["long-term debt obligations3", "22372", "429", "2360", "3761", "15822"], ["other long-term liabilities4 5", "1496", "569", "663", "144", "120"], ["total6", "$ 32100", "$ 7353", "$ 4190", "$ 4378", "$ 16179"]], "table_ori": [["", "Payments Due by Period"], ["(In Millions)", "Total", "Less Than1 Year", "1–3 Years", "3–5 Years", "More Than5 Years"], ["Operating lease obligations", "$870", "$208", "$298", "$166", "$198"], ["Capital purchase obligations<sup>1</sup>", "5,503", "5,375", "125", "—", "3"], ["Other purchase obligations and commitments<sup>2</sup>", "1,859", "772", "744", "307", "36"], ["Long-term debt obligations<sup>3</sup>", "22,372", "429", "2,360", "3,761", "15,822"], ["Other long-term liabilities<sup>4, 5</sup>", "1,496", "569", "663", "144", "120"], ["Total<sup>6</sup>", "$32,100", "$7,353", "$4,190", "$4,378", "$16,179"]]} | divide(22372, 32100) |
in 2013 what was the percent of the net cash used for investing activities to the net cash provided by operating activities | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_47.pdf-4", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "86.9%", "exe_answer": 0.8699} | {"table_1": "( in millions ) the net cash provided by operating activities of 2013 is $ 20776 ; the net cash provided by operating activities of 2012 is $ 18884 ; the net cash provided by operating activities of 2011 is $ 20963 ;", "table_2": "( in millions ) the net cash used for investing activities of 2013 is -18073 ( 18073 ) ; the net cash used for investing activities of 2012 is -14060 ( 14060 ) ; the net cash used for investing activities of 2011 is -10301 ( 10301 ) ;"} | {"pre_text": ["in summary , our cash flows for each period were as follows: ."], "post_text": ["operating activities cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities .", "for 2013 compared to 2012 , the $ 1.9 billion increase in cash provided by operating activities was due to changes in working capital , partially offset by lower net income in 2013 .", "income taxes paid , net of refunds , in 2013 compared to 2012 were $ 1.1 billion lower due to lower income before taxes in 2013 and 2012 income tax overpayments .", "changes in assets and liabilities as of december 28 , 2013 , compared to december 29 , 2012 , included lower income taxes payable and receivable resulting from a reduction in taxes due in 2013 , and lower inventories due to the sell-through of older-generation products , partially offset by the ramp of 4th generation intel core processor family products .", "for 2013 , our three largest customers accounted for 44% ( 44 % ) of our net revenue ( 43% ( 43 % ) in 2012 and 2011 ) , with hewlett- packard company accounting for 17% ( 17 % ) of our net revenue ( 18% ( 18 % ) in 2012 and 19% ( 19 % ) in 2011 ) , dell accounting for 15% ( 15 % ) of our net revenue ( 14% ( 14 % ) in 2012 and 15% ( 15 % ) in 2011 ) , and lenovo accounting for 12% ( 12 % ) of our net revenue ( 11% ( 11 % ) in 2012 and 9% ( 9 % ) in 2011 ) .", "these three customers accounted for 34% ( 34 % ) of our accounts receivable as of december 28 , 2013 ( 33% ( 33 % ) as of december 29 , 2012 ) .", "for 2012 compared to 2011 , the $ 2.1 billion decrease in cash provided by operating activities was due to lower net income and changes in our working capital , partially offset by adjustments for non-cash items .", "the adjustments for noncash items were higher due primarily to higher depreciation in 2012 compared to 2011 , partially offset by increases in non-acquisition-related deferred tax liabilities as of december 31 , 2011 .", "investing activities investing cash flows consist primarily of capital expenditures ; investment purchases , sales , maturities , and disposals ; as well as cash used for acquisitions .", "the increase in cash used for investing activities in 2013 compared to 2012 was primarily due to an increase in purchases of available-for-sale investments and a decrease in maturities and sales of trading assets , partially offset by an increase in maturities and sales of available-for-sale investments and a decrease in purchases of licensed technology and patents .", "our capital expenditures were $ 10.7 billion in 2013 ( $ 11.0 billion in 2012 and $ 10.8 billion in 2011 ) .", "cash used for investing activities increased in 2012 compared to 2011 primarily due to net purchases of available- for-sale investments and trading assets in 2012 , as compared to net maturities and sales of available-for-sale investments and trading assets in 2011 , partially offset by a decrease in cash paid for acquisitions .", "net purchases of available-for-sale investments in 2012 included our purchase of $ 3.2 billion of equity securities in asml in q3 2012 .", "financing activities financing cash flows consist primarily of repurchases of common stock , payment of dividends to stockholders , issuance and repayment of long-term debt , and proceeds from the sale of shares through employee equity incentive plans .", "table of contents management 2019s discussion and analysis of financial condition and results of operations ( continued ) ."], "table": [["( in millions )", "2013", "2012", "2011"], ["net cash provided by operating activities", "$ 20776", "$ 18884", "$ 20963"], ["net cash used for investing activities", "-18073 ( 18073 )", "-14060 ( 14060 )", "-10301 ( 10301 )"], ["net cash used for financing activities", "-5498 ( 5498 )", "-1408 ( 1408 )", "-11100 ( 11100 )"], ["effect of exchange rate fluctuations on cash and cash equivalents", "-9 ( 9 )", "-3 ( 3 )", "5"], ["net increase ( decrease ) in cash and cash equivalents", "$ -2804 ( 2804 )", "$ 3413", "$ -433 ( 433 )"]], "table_ori": [["(In Millions)", "2013", "2012", "2011"], ["Net cash provided by operating activities", "$20,776", "$18,884", "$20,963"], ["Net cash used for investing activities", "(18,073)", "(14,060)", "(10,301)"], ["Net cash used for financing activities", "(5,498)", "(1,408)", "(11,100)"], ["Effect of exchange rate fluctuations on cash and cash equivalents", "(9)", "(3)", "5"], ["Net increase (decrease) in cash and cash equivalents", "$(2,804)", "$3,413", "$(433)"]]} | divide(18073, 20776) |
what is the net cash flow from long-term debt during 2013? | {"label_key": "INTC_2013", "label_file": "fin_qa", "q_uid": "INTC/2013/page_86.pdf-1", "benchmark_name": "uda_fin_qa", "benchmark_type": "uda", "sub_benchmark": "fin_qa", "split": "default"} | {"str_answer": "29", "exe_answer": 29.0} | {"table_10": "( in millions ) the total long-term debt of dec 282013 is $ 13165 ; the total long-term debt of dec 292012 is $ 13136 ;"} | {"pre_text": ["note 15 : chipset design issue in january 2011 , as part of our ongoing quality assurance procedures , we identified a design issue with the intel ae 6 series express chipset family .", "the issue affected chipsets sold in the fourth quarter of 2010 and january 2011 .", "we subsequently implemented a silicon fix and began shipping the updated version of the affected chipset in february 2011 .", "the total cost in 2011 to repair and replace affected materials and systems , located with customers and in the market , was $ 422 million .", "we do not expect to have any significant future adjustments related to this issue .", "note 16 : borrowings short-term debt as of december 28 , 2013 , short-term debt consisted of drafts payable of $ 257 million and notes payable of $ 24 million ( drafts payable of $ 264 million and notes payable of $ 48 million as of december 29 , 2012 ) .", "we have an ongoing authorization from our board of directors to borrow up to $ 3.0 billion , including through the issuance of commercial paper .", "maximum borrowings under our commercial paper program during 2013 were $ 300 million ( $ 500 million during 2012 ) .", "our commercial paper was rated a-1+ by standard & poor 2019s and p-1 by moody 2019s as of december 28 , 2013 .", "long-term debt our long-term debt at the end of each period was as follows : ( in millions ) dec 28 , dec 29 ."], "post_text": ["senior notes in the fourth quarter of 2012 , we issued $ 6.2 billion aggregate principal amount of senior unsecured notes for general corporate purposes and to repurchase shares of our common stock pursuant to our authorized common stock repurchase program .", "in the third quarter of 2011 , we issued $ 5.0 billion aggregate principal amount of senior unsecured notes , primarily to repurchase shares of our common stock pursuant to our authorized common stock repurchase program , and for general corporate purposes .", "our senior notes pay a fixed rate of interest semiannually .", "we may redeem our senior notes , in whole or in part , at any time at our option at specified redemption prices .", "the senior notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and will effectively rank junior to all liabilities of our subsidiaries .", "table of contents intel corporation notes to consolidated financial statements ( continued ) ."], "table": [["( in millions )", "dec 282013", "dec 292012"], ["2012 senior notes due 2017 at 1.35% ( 1.35 % )", "$ 2997", "$ 2997"], ["2012 senior notes due 2022 at 2.70% ( 2.70 % )", "1494", "1494"], ["2012 senior notes due 2032 at 4.00% ( 4.00 % )", "744", "743"], ["2012 senior notes due 2042 at 4.25% ( 4.25 % )", "924", "924"], ["2011 senior notes due 2016 at 1.95% ( 1.95 % )", "1499", "1498"], ["2011 senior notes due 2021 at 3.30% ( 3.30 % )", "1996", "1996"], ["2011 senior notes due 2041 at 4.80% ( 4.80 % )", "1490", "1489"], ["2009 junior subordinated convertible debentures due 2039 at 3.25% ( 3.25 % )", "1075", "1063"], ["2005 junior subordinated convertible debentures due 2035 at 2.95% ( 2.95 % )", "946", "932"], ["total long-term debt", "$ 13165", "$ 13136"]], "table_ori": [["(In Millions)", "Dec 28,2013", "Dec 29,2012"], ["2012 Senior notes due 2017 at 1.35%", "$2,997", "$2,997"], ["2012 Senior notes due 2022 at 2.70%", "1,494", "1,494"], ["2012 Senior notes due 2032 at 4.00%", "744", "743"], ["2012 Senior notes due 2042 at 4.25%", "924", "924"], ["2011 Senior notes due 2016 at 1.95%", "1,499", "1,498"], ["2011 Senior notes due 2021 at 3.30%", "1,996", "1,996"], ["2011 Senior notes due 2041 at 4.80%", "1,490", "1,489"], ["2009 Junior subordinated convertible debentures due 2039 at 3.25%", "1,075", "1,063"], ["2005 Junior subordinated convertible debentures due 2035 at 2.95%", "946", "932"], ["Total long-term debt", "$13,165", "$13,136"]]} | subtract(13165, 13136) |
UDA FinQA (orgrctera/uda_fin_qa)
Overview
This dataset is the FinQA slice of the UDA (Unstructured Document Analysis) benchmark: 8,190 question–answer instances derived from real financial reports, packaged for retrieval-oriented evaluation in RAG pipelines.
UDA is a benchmark suite for Retrieval-Augmented Generation (RAG) over messy, real-world documents (PDF/HTML) where evidence mixes narrative text and tables. The finance portion includes large subsets aligned with FinQA-style numerical reasoning over earnings materials.
FinQA (Chen et al., EMNLP 2021) is the foundational dataset of expert-written questions over financial reports, with heterogeneous evidence (tables + text) and multi-step numerical reasoning. UDA adopts FinQA-aligned labeling within its broader document-analysis benchmark (Hui et al., NeurIPS 2024 Datasets & Benchmarks).
In this Hub release, each row is a retrieval task instance: the model must locate and use the right evidence (typically embedded in expected_output as structured context for scoring or teacher forcing) to answer the question in input, consistent with the FinQA / UDA evaluation setting where retrieval quality and parsing of unstructured financial documents are central.
Task
- Task type: Retrieval (within a RAG / document-analysis pipeline) for FinQA-style financial QA.
- Input: A natural-language question (
input) about reported figures or relationships in corporate financial disclosures. - Supervision / reference:
expected_outputis a JSON string containing gold answers, evidence pointers, and document context (see below). Metadata records UDA benchmark identifiers (sub_benchmark:fin_qa).
Models are typically evaluated by whether retrieved passages support the correct answer and whether generation matches gold reasoning or numeric targets, following the FinQA and UDA protocols.
Background
FinQA
FinQA targets numerical reasoning over financial data: questions are written by finance experts over real reports; annotations include explainable reasoning traces. The original work shows that general-domain pretrained LMs lag humans on finance-specific, multi-step numeric reasoning.
UDA benchmark
UDA revisits RAG and LLM-based document analysis across domains (including finance) using thousands of real documents and tens of thousands of expert-annotated Q&A pairs, with documents kept in original formats to stress parsing, chunking, and retrieval—not only generation.
The FinQA-related finance split in UDA (reported in the UDA paper as part of the finance track) corresponds to the scale of this dataset (8,190 examples in the default split here).
Data fields
| Column | Type | Description |
|---|---|---|
input |
string |
Question text posed over the report. |
expected_output |
string |
JSON string with fields such as answers (e.g. str_answer, exe_answer), evidence (table/text references), and context (supporting pre/post text and table snippets). |
metadata |
struct | benchmark_name (uda_fin_qa), benchmark_type (uda), split, sub_benchmark (fin_qa), and value (JSON string with identifiers like label_key, label_file, q_uid). |
Splits: Single split default with 8,190 examples.
Examples
Example rows are illustrative; long context blocks are abbreviated.
Example 1 — interest expense
input:what is the the interest expense in 2009?expected_output(excerpt):
{
"answers": {"str_answer": "380", "exe_answer": 3.8},
"evidence": {
"text_1": "if libor changes by 100 basis points , our annual interest expense would change by $ 3.8 million ."
},
"context": {
"pre_text": [
"interest rate to a variable interest rate based on the three-month libor plus 2.05% ...",
"if libor changes by 100 basis points , our annual interest expense would change by $ 3.8 million .",
"..."
]
}
}
Example 2 — amortization growth
input:what is the expected growth rate in amortization expense in 2010?expected_output(excerpt):
{
"answers": {"str_answer": "-27.0%", "exe_answer": -0.26689},
"evidence": {
"table_1": "fiscal years the 2010 of amortization expense is $ 5425 ;",
"text_2": "amortization expense from continuing operations , related to intangibles was $ 7.4 million , $ 9.3 million and $ 9.2 million in fiscal 2009 , 2008 and 2007 , respectively ."
},
"context": { "...": "..." }
}
metadata.value (example):
{"label_key": "ADI_2009", "label_file": "fin_qa", "q_uid": "ADI/2009/page_49.pdf-1"}
References
FinQA (source task & data lineage)
Zhiyu Chen, Wenhu Chen, Charese Smiley, Sameena Shah, Iana Borova, Dylan Langdon, Reema Moussa, Matt Beane, Ting-Hao Huang, Bryan Routledge, William Yang Wang. FinQA: A Dataset of Numerical Reasoning over Financial Data. EMNLP 2021, pages 3697–3711.
- Abstract (short): Introduces a large-scale dataset of QA pairs over financial reports with gold reasoning programs for explainability; shows that large pretrained models fall short of experts on finance knowledge and multi-step numerical reasoning.
- ACL Anthology: https://aclanthology.org/2021.emnlp-main.300/
- DOI: 10.18653/v1/2021.emnlp-main.300
- Code & data (original release): https://github.com/czyssrs/FinQA
UDA benchmark (suite containing this FinQA slice)
Yulong Hui, Yao Lu, Huanchen Zhang. UDA: A Benchmark Suite for Retrieval Augmented Generation in Real-world Document Analysis. NeurIPS 2024 (Datasets and Benchmarks Track).
- Abstract (short): Presents UDA with thousands of real-world documents and tens of thousands of expert-annotated Q&A pairs; evaluates LLM- and RAG-based document analysis and highlights parsing and retrieval design choices.
- arXiv: https://arxiv.org/abs/2406.15187
- arXiv DOI: 10.48550/arXiv.2406.15187
- NeurIPS proceedings: https://proceedings.neurips.cc/paper_files/paper/2024/hash/7c06759d1a8567f087b02e8589454917-Abstract-Datasets_and_Benchmarks_Track.html
- Code & resources: https://github.com/qinchuanhui/UDA-Benchmark
Related Hub resources
- UDA QA aggregation (reference): qinchuanhui/UDA-QA
Citation
If you use this dataset, please cite both FinQA and UDA (and this dataset record as appropriate):
@inproceedings{chen-etal-2021-finqa,
title = {FinQA: A Dataset of Numerical Reasoning over Financial Data},
author = {Chen, Zhiyu and Chen, Wenhu and Smiley, Charese and Shah, Sameena and Borova, Iana and Langdon, Dylan and Moussa, Reema and Beane, Matt and Huang, Ting-Hao and Routledge, Bryan and Wang, William Yang},
booktitle = {Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing},
year = {2021},
pages = {3697--3711}
}
@article{hui2024uda,
title = {UDA: A Benchmark Suite for Retrieval Augmented Generation in Real-world Document Analysis},
author = {Hui, Yulong and Lu, Yao and Zhang, Huanchen},
journal = {arXiv preprint arXiv:2406.15187},
year = {2024}
}
License
The original FinQA release is under the MIT License (see the FinQA repository). Use this dataset in compliance with the original data licenses and the UDA benchmark terms.
- Downloads last month
- 7